#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


Text=A Framework for Linking Resting-state Chronnectome/Genome Features in Schizophrenia: A Pilot Study Multimodal, imaging-genomics techniques offer a platform for understanding genetic influences on brain abnormalities in psychiatric disorders.
1-1	0-1	A	_
1-2	2-11	Framework	_
1-3	12-15	for	_
1-4	16-23	Linking	_
1-5	24-37	Resting-state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
1-6	38-57	Chronnectome/Genome	_
1-7	58-66	Features	_
1-8	67-69	in	_
1-9	70-83	Schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
1-10	84-85	:	_
1-11	86-87	A	_
1-12	88-93	Pilot	_
1-13	94-99	Study	_
1-14	100-110	Multimodal	_
1-15	111-112	,	_
1-16	113-129	imaging-genomics	_
1-17	130-140	techniques	_
1-18	141-146	offer	_
1-19	147-148	a	_
1-20	149-157	platform	_
1-21	158-161	for	_
1-22	162-175	understanding	_
1-23	176-183	genetic	_
1-24	184-194	influences	_
1-25	195-197	on	_
1-26	198-203	brain	_
1-27	204-217	abnormalities	_
1-28	218-220	in	_
1-29	221-232	psychiatric	_
1-30	233-242	disorders	_
1-31	243-244	.	_

Text=Such approaches utilize the information available from both imaging and genomics data and identify their association.
2-1	245-249	Such	_
2-2	250-260	approaches	_
2-3	261-268	utilize	_
2-4	269-272	the	_
2-5	273-284	information	_
2-6	285-294	available	_
2-7	295-299	from	_
2-8	300-304	both	_
2-9	305-312	imaging	_
2-10	313-316	and	_
2-11	317-325	genomics	_
2-12	326-330	data	_
2-13	331-334	and	_
2-14	335-343	identify	_
2-15	344-349	their	_
2-16	350-361	association	_
2-17	362-363	.	_

Text=Particularly for complex disorders such as schizophrenia, the relationship between imaging and genomic features may be better understood by incorporating additional information provided by advanced multimodal modeling.
3-1	364-376	Particularly	_
3-2	377-380	for	_
3-3	381-388	complex	_
3-4	389-398	disorders	_
3-5	399-403	such	_
3-6	404-406	as	_
3-7	407-420	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
3-8	421-422	,	_
3-9	423-426	the	_
3-10	427-439	relationship	_
3-11	440-447	between	_
3-12	448-455	imaging	_
3-13	456-459	and	_
3-14	460-467	genomic	_
3-15	468-476	features	_
3-16	477-480	may	_
3-17	481-483	be	_
3-18	484-490	better	_
3-19	491-501	understood	_
3-20	502-504	by	_
3-21	505-518	incorporating	_
3-22	519-529	additional	_
3-23	530-541	information	_
3-24	542-550	provided	_
3-25	551-553	by	_
3-26	554-562	advanced	_
3-27	563-573	multimodal	_
3-28	574-582	modeling	_
3-29	583-584	.	_

Text=In this study, we propose a novel framework to combine features corresponding to functional magnetic resonance imaging (functional) and single nucleotide polymorphism (SNP) data from 61 schizophrenia (SZ) patients and 87 healthy controls (HC).
4-1	585-587	In	_
4-2	588-592	this	_
4-3	593-598	study	_
4-4	599-600	,	_
4-5	601-603	we	_
4-6	604-611	propose	_
4-7	612-613	a	_
4-8	614-619	novel	_
4-9	620-629	framework	_
4-10	630-632	to	_
4-11	633-640	combine	_
4-12	641-649	features	_
4-13	650-663	corresponding	_
4-14	664-666	to	_
4-15	667-677	functional	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
4-16	678-686	magnetic	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
4-17	687-696	resonance	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
4-18	697-704	imaging	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
4-19	705-706	(	_
4-20	707-717	functional	_
4-21	718-719	)	_
4-22	720-723	and	_
4-23	724-730	single	_
4-24	731-741	nucleotide	_
4-25	742-754	polymorphism	_
4-26	755-756	(	_
4-27	757-760	SNP	_
4-28	761-762	)	_
4-29	763-767	data	_
4-30	768-772	from	_
4-31	773-775	61	_
4-32	776-789	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
4-33	790-791	(	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
4-34	792-794	SZ	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
4-35	795-796	)	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
4-36	797-805	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
4-37	806-809	and	_
4-38	810-812	87	_
4-39	813-820	healthy	http://maven.renci.org/NeuroBridge/neurobridge#ControlSubject
4-40	821-829	controls	http://maven.renci.org/NeuroBridge/neurobridge#ControlSubject
4-41	830-831	(	http://maven.renci.org/NeuroBridge/neurobridge#ControlSubject
4-42	832-834	HC	http://maven.renci.org/NeuroBridge/neurobridge#ControlSubject
4-43	835-836	)	_
4-44	837-838	.	_

Text=In particular, the features for the functional and genetic modalities include dynamic (i.e., time-varying) functional network connectivity (dFNC) features and the SNP data, respectively.
5-1	839-841	In	_
5-2	842-852	particular	_
5-3	853-854	,	_
5-4	855-858	the	_
5-5	859-867	features	_
5-6	868-871	for	_
5-7	872-875	the	_
5-8	876-886	functional	_
5-9	887-890	and	_
5-10	891-898	genetic	_
5-11	899-909	modalities	_
5-12	910-917	include	_
5-13	918-925	dynamic	_
5-14	926-927	(	_
5-15	928-932	i.e.	_
5-16	933-934	,	_
5-17	935-947	time-varying	_
5-18	948-949	)	_
5-19	950-960	functional	_
5-20	961-968	network	_
5-21	969-981	connectivity	_
5-22	982-983	(	_
5-23	984-988	dFNC	_
5-24	989-990	)	_
5-25	991-999	features	_
5-26	1000-1003	and	_
5-27	1004-1007	the	_
5-28	1008-1011	SNP	_
5-29	1012-1016	data	_
5-30	1017-1018	,	_
5-31	1019-1031	respectively	_
5-32	1032-1033	.	_

Text=The dFNC features are estimated from component time-courses, obtained using group independent component analysis (ICA), by computing sliding-window functional network connectivity, and then estimating subject specific states from this dFNC data using a k-means clustering approach.
6-1	1034-1037	The	_
6-2	1038-1042	dFNC	_
6-3	1043-1051	features	_
6-4	1052-1055	are	_
6-5	1056-1065	estimated	_
6-6	1066-1070	from	_
6-7	1071-1080	component	_
6-8	1081-1093	time-courses	_
6-9	1094-1095	,	_
6-10	1096-1104	obtained	_
6-11	1105-1110	using	_
6-12	1111-1116	group	_
6-13	1117-1128	independent	_
6-14	1129-1138	component	_
6-15	1139-1147	analysis	_
6-16	1148-1149	(	_
6-17	1150-1153	ICA	_
6-18	1154-1155	)	_
6-19	1156-1157	,	_
6-20	1158-1160	by	_
6-21	1161-1170	computing	_
6-22	1171-1185	sliding-window	_
6-23	1186-1196	functional	_
6-24	1197-1204	network	_
6-25	1205-1217	connectivity	_
6-26	1218-1219	,	_
6-27	1220-1223	and	_
6-28	1224-1228	then	_
6-29	1229-1239	estimating	_
6-30	1240-1247	subject	_
6-31	1248-1256	specific	_
6-32	1257-1263	states	_
6-33	1264-1268	from	_
6-34	1269-1273	this	_
6-35	1274-1278	dFNC	_
6-36	1279-1283	data	_
6-37	1284-1289	using	_
6-38	1290-1291	a	_
6-39	1292-1299	k-means	_
6-40	1300-1310	clustering	_
6-41	1311-1319	approach	_
6-42	1320-1321	.	_

Text=For each subject, both the functional (dFNC states) and SNP data are selected as features for a parallel ICA (pICA) based imaging-genomic framework.
7-1	1322-1325	For	_
7-2	1326-1330	each	_
7-3	1331-1338	subject	_
7-4	1339-1340	,	_
7-5	1341-1345	both	_
7-6	1346-1349	the	_
7-7	1350-1360	functional	_
7-8	1361-1362	(	_
7-9	1363-1367	dFNC	_
7-10	1368-1374	states	_
7-11	1375-1376	)	_
7-12	1377-1380	and	_
7-13	1381-1384	SNP	_
7-14	1385-1389	data	_
7-15	1390-1393	are	_
7-16	1394-1402	selected	_
7-17	1403-1405	as	_
7-18	1406-1414	features	_
7-19	1415-1418	for	_
7-20	1419-1420	a	_
7-21	1421-1429	parallel	_
7-22	1430-1433	ICA	_
7-23	1434-1435	(	_
7-24	1436-1440	pICA	_
7-25	1441-1442	)	_
7-26	1443-1448	based	_
7-27	1449-1464	imaging-genomic	_
7-28	1465-1474	framework	_
7-29	1475-1476	.	_

Text=This analysis identified a significant association between a SNP component (defined by large clusters of functionally related SNPs statistically correlated with phenotype components) and time-varying or dFNC component (defined by clusters of related connectivity links among distant brain regions distributed across discrete dynamic states, and statistically correlated with genomic components) in schizophrenia.
8-1	1477-1481	This	_
8-2	1482-1490	analysis	_
8-3	1491-1501	identified	_
8-4	1502-1503	a	_
8-5	1504-1515	significant	_
8-6	1516-1527	association	_
8-7	1528-1535	between	_
8-8	1536-1537	a	_
8-9	1538-1541	SNP	_
8-10	1542-1551	component	_
8-11	1552-1553	(	_
8-12	1554-1561	defined	_
8-13	1562-1564	by	_
8-14	1565-1570	large	_
8-15	1571-1579	clusters	_
8-16	1580-1582	of	_
8-17	1583-1595	functionally	_
8-18	1596-1603	related	_
8-19	1604-1608	SNPs	_
8-20	1609-1622	statistically	_
8-21	1623-1633	correlated	_
8-22	1634-1638	with	_
8-23	1639-1648	phenotype	_
8-24	1649-1659	components	_
8-25	1660-1661	)	_
8-26	1662-1665	and	_
8-27	1666-1678	time-varying	_
8-28	1679-1681	or	_
8-29	1682-1686	dFNC	_
8-30	1687-1696	component	_
8-31	1697-1698	(	_
8-32	1699-1706	defined	_
8-33	1707-1709	by	_
8-34	1710-1718	clusters	_
8-35	1719-1721	of	_
8-36	1722-1729	related	_
8-37	1730-1742	connectivity	_
8-38	1743-1748	links	_
8-39	1749-1754	among	_
8-40	1755-1762	distant	_
8-41	1763-1768	brain	_
8-42	1769-1776	regions	_
8-43	1777-1788	distributed	_
8-44	1789-1795	across	_
8-45	1796-1804	discrete	_
8-46	1805-1812	dynamic	_
8-47	1813-1819	states	_
8-48	1820-1821	,	_
8-49	1822-1825	and	_
8-50	1826-1839	statistically	_
8-51	1840-1850	correlated	_
8-52	1851-1855	with	_
8-53	1856-1863	genomic	_
8-54	1864-1874	components	_
8-55	1875-1876	)	_
8-56	1877-1879	in	_
8-57	1880-1893	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
8-58	1894-1895	.	_

Text=Importantly, the polygenetic risk score (PRS) for SZ (computed as a linearly weighted sum of the genotype profiles with weights derived from the odds ratios of the psychiatric genomics consortium (PGC)) was negatively correlated with the significant dFNC component, which were mostly present within a state that exhibited a lower occupancy rate in individuals with SZ compared with HC, hence identifying a potential dFNC imaging biomarker for schizophrenia.
9-1	1896-1907	Importantly	_
9-2	1908-1909	,	_
9-3	1910-1913	the	_
9-4	1914-1925	polygenetic	_
9-5	1926-1930	risk	_
9-6	1931-1936	score	_
9-7	1937-1938	(	_
9-8	1939-1942	PRS	_
9-9	1943-1944	)	_
9-10	1945-1948	for	_
9-11	1949-1951	SZ	http://maven.renci.org/NeuroBridge/neurobridge#Thing
9-12	1952-1953	(	_
9-13	1954-1962	computed	_
9-14	1963-1965	as	_
9-15	1966-1967	a	_
9-16	1968-1976	linearly	_
9-17	1977-1985	weighted	_
9-18	1986-1989	sum	_
9-19	1990-1992	of	_
9-20	1993-1996	the	_
9-21	1997-2005	genotype	_
9-22	2006-2014	profiles	_
9-23	2015-2019	with	_
9-24	2020-2027	weights	_
9-25	2028-2035	derived	_
9-26	2036-2040	from	_
9-27	2041-2044	the	_
9-28	2045-2049	odds	_
9-29	2050-2056	ratios	_
9-30	2057-2059	of	_
9-31	2060-2063	the	_
9-32	2064-2075	psychiatric	_
9-33	2076-2084	genomics	_
9-34	2085-2095	consortium	_
9-35	2096-2097	(	_
9-36	2098-2101	PGC	_
9-37	2102-2103	)	_
9-38	2104-2105	)	_
9-39	2106-2109	was	_
9-40	2110-2120	negatively	_
9-41	2121-2131	correlated	_
9-42	2132-2136	with	_
9-43	2137-2140	the	_
9-44	2141-2152	significant	_
9-45	2153-2157	dFNC	_
9-46	2158-2167	component	_
9-47	2168-2169	,	_
9-48	2170-2175	which	_
9-49	2176-2180	were	_
9-50	2181-2187	mostly	_
9-51	2188-2195	present	_
9-52	2196-2202	within	_
9-53	2203-2204	a	_
9-54	2205-2210	state	_
9-55	2211-2215	that	_
9-56	2216-2225	exhibited	_
9-57	2226-2227	a	_
9-58	2228-2233	lower	_
9-59	2234-2243	occupancy	_
9-60	2244-2248	rate	_
9-61	2249-2251	in	_
9-62	2252-2263	individuals	_
9-63	2264-2268	with	_
9-64	2269-2271	SZ	http://maven.renci.org/NeuroBridge/neurobridge#Thing
9-65	2272-2280	compared	_
9-66	2281-2285	with	_
9-67	2286-2288	HC	_
9-68	2289-2290	,	_
9-69	2291-2296	hence	_
9-70	2297-2308	identifying	_
9-71	2309-2310	a	_
9-72	2311-2320	potential	_
9-73	2321-2325	dFNC	_
9-74	2326-2333	imaging	_
9-75	2334-2343	biomarker	_
9-76	2344-2347	for	_
9-77	2348-2361	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
9-78	2362-2363	.	_

Text=Taken together, the current findings provide preliminary evidence for a link between dFNC measures and genetic risk, suggesting the application of dFNC patterns as biomarkers in imaging genetic association study.
10-1	2364-2369	Taken	_
10-2	2370-2378	together	_
10-3	2379-2380	,	_
10-4	2381-2384	the	_
10-5	2385-2392	current	_
10-6	2393-2401	findings	_
10-7	2402-2409	provide	_
10-8	2410-2421	preliminary	_
10-9	2422-2430	evidence	_
10-10	2431-2434	for	_
10-11	2435-2436	a	_
10-12	2437-2441	link	_
10-13	2442-2449	between	_
10-14	2450-2454	dFNC	_
10-15	2455-2463	measures	_
10-16	2464-2467	and	_
10-17	2468-2475	genetic	_
10-18	2476-2480	risk	_
10-19	2481-2482	,	_
10-20	2483-2493	suggesting	_
10-21	2494-2497	the	_
10-22	2498-2509	application	_
10-23	2510-2512	of	_
10-24	2513-2517	dFNC	_
10-25	2518-2526	patterns	_
10-26	2527-2529	as	_
10-27	2530-2540	biomarkers	_
10-28	2541-2543	in	_
10-29	2544-2551	imaging	_
10-30	2552-2559	genetic	_
10-31	2560-2571	association	_
10-32	2572-2577	study	_
10-33	2578-2579	.	_

Text=MATERIALS AND METHODS Participants We used resting-state functional magnetic resonance imaging (fMRI) data and single nucleotide polymorphism (SNP) data obtained from 87 healthy controls (61 males, 26 females; mean age 36.83) and 61 age- and gender matched patients with SZ (52 males, 9 females; mean age 38.36) during eyes closed condition as part of the multi-site fBIRN project.
11-1	2580-2589	MATERIALS	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
11-2	2590-2593	AND	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
11-3	2594-2601	METHODS	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
11-4	2602-2614	Participants	_
11-5	2615-2617	We	_
11-6	2618-2622	used	_
11-7	2623-2636	resting-state	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
11-8	2637-2647	functional	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
11-9	2648-2656	magnetic	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
11-10	2657-2666	resonance	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
11-11	2667-2674	imaging	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
11-12	2675-2676	(	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
11-13	2677-2681	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
11-14	2682-2683	)	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
11-15	2684-2688	data	_
11-16	2689-2692	and	_
11-17	2693-2699	single	_
11-18	2700-2710	nucleotide	_
11-19	2711-2723	polymorphism	_
11-20	2724-2725	(	_
11-21	2726-2729	SNP	_
11-22	2730-2731	)	_
11-23	2732-2736	data	_
11-24	2737-2745	obtained	_
11-25	2746-2750	from	_
11-26	2751-2753	87	_
11-27	2754-2761	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
11-28	2762-2770	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
11-29	2771-2772	(	_
11-30	2773-2775	61	_
11-31	2776-2781	males	_
11-32	2782-2783	,	_
11-33	2784-2786	26	_
11-34	2787-2794	females	_
11-35	2795-2796	;	_
11-36	2797-2801	mean	_
11-37	2802-2805	age	_
11-38	2806-2811	36.83	_
11-39	2812-2813	)	_
11-40	2814-2817	and	_
11-41	2818-2820	61	_
11-42	2821-2825	age-	_
11-43	2826-2829	and	_
11-44	2830-2836	gender	_
11-45	2837-2844	matched	_
11-46	2845-2853	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
11-47	2854-2858	with	_
11-48	2859-2861	SZ	http://maven.renci.org/NeuroBridge/neurobridge#Thing
11-49	2862-2863	(	_
11-50	2864-2866	52	_
11-51	2867-2872	males	_
11-52	2873-2874	,	_
11-53	2875-2876	9	_
11-54	2877-2884	females	_
11-55	2885-2886	;	_
11-56	2887-2891	mean	_
11-57	2892-2895	age	_
11-58	2896-2901	38.36	_
11-59	2902-2903	)	_
11-60	2904-2910	during	_
11-61	2911-2915	eyes	_
11-62	2916-2922	closed	_
11-63	2923-2932	condition	_
11-64	2933-2935	as	_
11-65	2936-2940	part	_
11-66	2941-2943	of	_
11-67	2944-2947	the	_
11-68	2948-2958	multi-site	_
11-69	2959-2964	fBIRN	_
11-70	2965-2972	project	_
11-71	2973-2974	.	_

Text=Informed consent was obtained from each participant prior to scanning in accordance with the Internal Review Boards of corresponding institutions.
12-1	2975-2983	Informed	_
12-2	2984-2991	consent	_
12-3	2992-2995	was	_
12-4	2996-3004	obtained	_
12-5	3005-3009	from	_
12-6	3010-3014	each	_
12-7	3015-3026	participant	_
12-8	3027-3032	prior	_
12-9	3033-3035	to	_
12-10	3036-3044	scanning	_
12-11	3045-3047	in	_
12-12	3048-3058	accordance	_
12-13	3059-3063	with	_
12-14	3064-3067	the	_
12-15	3068-3076	Internal	_
12-16	3077-3083	Review	_
12-17	3084-3090	Boards	_
12-18	3091-3093	of	_
12-19	3094-3107	corresponding	_
12-20	3108-3120	institutions	_
12-21	3121-3122	.	_

Text=SNP Data Preprocessing and Feature Selection DNA was extracted from blood and saliva samples collected from the participants.
13-1	3123-3126	SNP	_
13-2	3127-3131	Data	_
13-3	3132-3145	Preprocessing	_
13-4	3146-3149	and	_
13-5	3150-3157	Feature	_
13-6	3158-3167	Selection	_
13-7	3168-3171	DNA	_
13-8	3172-3175	was	_
13-9	3176-3185	extracted	_
13-10	3186-3190	from	_
13-11	3191-3196	blood	_
13-12	3197-3200	and	_
13-13	3201-3207	saliva	_
13-14	3208-3215	samples	_
13-15	3216-3225	collected	_
13-16	3226-3230	from	_
13-17	3231-3234	the	_
13-18	3235-3247	participants	_
13-19	3248-3249	.	_

Text=No significant difference was noted in genotyping call rates between blood and saliva samples.
14-1	3250-3252	No	_
14-2	3253-3264	significant	_
14-3	3265-3275	difference	_
14-4	3276-3279	was	_
14-5	3280-3285	noted	_
14-6	3286-3288	in	_
14-7	3289-3299	genotyping	_
14-8	3300-3304	call	_
14-9	3305-3310	rates	_
14-10	3311-3318	between	_
14-11	3319-3324	blood	_
14-12	3325-3328	and	_
14-13	3329-3335	saliva	_
14-14	3336-3343	samples	_
14-15	3344-3345	.	_

Text=DNA extraction was performed at the University of California at Irvine and genotyping was performed by Illumina (SD) using a custom made assay including the Infinium MEGAex chip as well all SNPs on the Psych chip.
15-1	3346-3349	DNA	_
15-2	3350-3360	extraction	_
15-3	3361-3364	was	_
15-4	3365-3374	performed	_
15-5	3375-3377	at	_
15-6	3378-3381	the	_
15-7	3382-3392	University	_
15-8	3393-3395	of	_
15-9	3396-3406	California	_
15-10	3407-3409	at	_
15-11	3410-3416	Irvine	_
15-12	3417-3420	and	_
15-13	3421-3431	genotyping	_
15-14	3432-3435	was	_
15-15	3436-3445	performed	_
15-16	3446-3448	by	_
15-17	3449-3457	Illumina	_
15-18	3458-3459	(	_
15-19	3460-3462	SD	_
15-20	3463-3464	)	_
15-21	3465-3470	using	_
15-22	3471-3472	a	_
15-23	3473-3479	custom	_
15-24	3480-3484	made	_
15-25	3485-3490	assay	_
15-26	3491-3500	including	_
15-27	3501-3504	the	_
15-28	3505-3513	Infinium	_
15-29	3514-3520	MEGAex	_
15-30	3521-3525	chip	_
15-31	3526-3528	as	_
15-32	3529-3533	well	_
15-33	3534-3537	all	_
15-34	3538-3542	SNPs	_
15-35	3543-3545	on	_
15-36	3546-3549	the	_
15-37	3550-3555	Psych	_
15-38	3556-3560	chip	_
15-39	3561-3562	.	_

Text=The SNP data went through quality control (QC), imputation and post-imputation QC as described in, which is briefly summarized here.
16-1	3563-3566	The	_
16-2	3567-3570	SNP	_
16-3	3571-3575	data	_
16-4	3576-3580	went	_
16-5	3581-3588	through	_
16-6	3589-3596	quality	_
16-7	3597-3604	control	_
16-8	3605-3606	(	_
16-9	3607-3609	QC	_
16-10	3610-3611	)	_
16-11	3612-3613	,	_
16-12	3614-3624	imputation	_
16-13	3625-3628	and	_
16-14	3629-3644	post-imputation	_
16-15	3645-3647	QC	_
16-16	3648-3650	as	_
16-17	3651-3660	described	_
16-18	3661-3663	in	_
16-19	3664-3665	,	_
16-20	3666-3671	which	_
16-21	3672-3674	is	_
16-22	3675-3682	briefly	_
16-23	3683-3693	summarized	_
16-24	3694-3698	here	_
16-25	3699-3700	.	_

Text=PLINK was employed for pre- and post-imputation QC, including: (a) gender consistency check, (b) sample relatedness (not closer than second degree relatives), (c) genotyping call rate (> 90% at both the individual and SNP level), (d) Hardy-Weinberg equilibrium in the control population (p <1 × 10 −6), (e) minor allele frequency (MAF> 0.05).
17-1	3701-3706	PLINK	_
17-2	3707-3710	was	_
17-3	3711-3719	employed	_
17-4	3720-3723	for	_
17-5	3724-3728	pre-	_
17-6	3729-3732	and	_
17-7	3733-3748	post-imputation	_
17-8	3749-3751	QC	_
17-9	3752-3753	,	_
17-10	3754-3763	including	_
17-11	3764-3765	:	_
17-12	3766-3767	(	_
17-13	3768-3769	a	_
17-14	3770-3771	)	_
17-15	3772-3778	gender	_
17-16	3779-3790	consistency	_
17-17	3791-3796	check	_
17-18	3797-3798	,	_
17-19	3799-3800	(	_
17-20	3801-3802	b	_
17-21	3803-3804	)	_
17-22	3805-3811	sample	_
17-23	3812-3823	relatedness	_
17-24	3824-3825	(	_
17-25	3826-3829	not	_
17-26	3830-3836	closer	_
17-27	3837-3841	than	_
17-28	3842-3848	second	_
17-29	3849-3855	degree	_
17-30	3856-3865	relatives	_
17-31	3866-3867	)	_
17-32	3868-3869	,	_
17-33	3870-3871	(	_
17-34	3872-3873	c	_
17-35	3874-3875	)	_
17-36	3876-3886	genotyping	_
17-37	3887-3891	call	_
17-38	3892-3896	rate	_
17-39	3897-3898	(	_
17-40	3899-3900	>	_
17-41	3901-3903	90	_
17-42	3904-3905	%	_
17-43	3906-3908	at	_
17-44	3909-3913	both	_
17-45	3914-3917	the	_
17-46	3918-3928	individual	_
17-47	3929-3932	and	_
17-48	3933-3936	SNP	_
17-49	3937-3942	level	_
17-50	3943-3944	)	_
17-51	3945-3946	,	_
17-52	3947-3948	(	_
17-53	3949-3950	d	_
17-54	3951-3952	)	_
17-55	3953-3967	Hardy-Weinberg	_
17-56	3968-3979	equilibrium	_
17-57	3980-3982	in	_
17-58	3983-3986	the	_
17-59	3987-3994	control	_
17-60	3995-4005	population	_
17-61	4006-4007	(	_
17-62	4008-4009	p	_
17-63	4010-4011	<	_
17-64	4012-4013	1	_
17-65	4014-4015	×	_
17-66	4016-4018	10	_
17-67	4019-4021	−6	_
17-68	4022-4023	)	_
17-69	4024-4025	,	_
17-70	4026-4027	(	_
17-71	4028-4029	e	_
17-72	4030-4031	)	_
17-73	4032-4037	minor	_
17-74	4038-4044	allele	_
17-75	4045-4054	frequency	_
17-76	4055-4056	(	_
17-77	4057-4060	MAF	_
17-78	4061-4062	>	_
17-79	4063-4067	0.05	_
17-80	4068-4069	)	_
17-81	4070-4071	.	_

Text=Then imputation was conducted with SHAPEIT used for pre-phasing, IMPUTE2 for imputation, and the 1000 Genomes data as the reference panel.
18-1	4072-4076	Then	_
18-2	4077-4087	imputation	_
18-3	4088-4091	was	_
18-4	4092-4101	conducted	_
18-5	4102-4106	with	_
18-6	4107-4114	SHAPEIT	_
18-7	4115-4119	used	_
18-8	4120-4123	for	_
18-9	4124-4135	pre-phasing	_
18-10	4136-4137	,	_
18-11	4138-4145	IMPUTE2	_
18-12	4146-4149	for	_
18-13	4150-4160	imputation	_
18-14	4161-4162	,	_
18-15	4163-4166	and	_
18-16	4167-4170	the	_
18-17	4171-4175	1000	_
18-18	4176-4183	Genomes	_
18-19	4184-4188	data	_
18-20	4189-4191	as	_
18-21	4192-4195	the	_
18-22	4196-4205	reference	_
18-23	4206-4211	panel	_
18-24	4212-4213	.	_

Text=Only markers with high imputation qualities (INFO score> 0.95) were retained.
19-1	4214-4218	Only	_
19-2	4219-4226	markers	_
19-3	4227-4231	with	_
19-4	4232-4236	high	_
19-5	4237-4247	imputation	_
19-6	4248-4257	qualities	_
19-7	4258-4259	(	_
19-8	4260-4264	INFO	_
19-9	4265-4270	score	_
19-10	4271-4272	>	_
19-11	4273-4277	0.95	_
19-12	4278-4279	)	_
19-13	4280-4284	were	_
19-14	4285-4293	retained	_
19-15	4294-4295	.	_

Text=Missing calls were replaced using high linkage disequilibrium (LD) loci if available or otherwise removed.
20-1	4296-4303	Missing	_
20-2	4304-4309	calls	_
20-3	4310-4314	were	_
20-4	4315-4323	replaced	_
20-5	4324-4329	using	_
20-6	4330-4334	high	_
20-7	4335-4342	linkage	_
20-8	4343-4357	disequilibrium	_
20-9	4358-4359	(	_
20-10	4360-4362	LD	_
20-11	4363-4364	)	_
20-12	4365-4369	loci	_
20-13	4370-4372	if	_
20-14	4373-4382	available	_
20-15	4383-4385	or	_
20-16	4386-4395	otherwise	_
20-17	4396-4403	removed	_
20-18	4404-4405	.	_

Text=A total of 977,242 SNP loci were obtained after post-imputation QC and LD pruning (r2 <0.9), and discrete numbers were then assigned to the categorical genotypes: 0 (no minor allele), 1 (one minor allele), and 2 (two minor alleles).
21-1	4406-4407	A	_
21-2	4408-4413	total	_
21-3	4414-4416	of	_
21-4	4417-4424	977,242	_
21-5	4425-4428	SNP	_
21-6	4429-4433	loci	_
21-7	4434-4438	were	_
21-8	4439-4447	obtained	_
21-9	4448-4453	after	_
21-10	4454-4469	post-imputation	_
21-11	4470-4472	QC	_
21-12	4473-4476	and	_
21-13	4477-4479	LD	_
21-14	4480-4487	pruning	_
21-15	4488-4489	(	_
21-16	4490-4492	r2	_
21-17	4493-4494	<	_
21-18	4495-4498	0.9	_
21-19	4499-4500	)	_
21-20	4501-4502	,	_
21-21	4503-4506	and	_
21-22	4507-4515	discrete	_
21-23	4516-4523	numbers	_
21-24	4524-4528	were	_
21-25	4529-4533	then	_
21-26	4534-4542	assigned	_
21-27	4543-4545	to	_
21-28	4546-4549	the	_
21-29	4550-4561	categorical	_
21-30	4562-4571	genotypes	_
21-31	4572-4573	:	_
21-32	4574-4575	0	_
21-33	4576-4577	(	_
21-34	4578-4580	no	_
21-35	4581-4586	minor	_
21-36	4587-4593	allele	_
21-37	4594-4595	)	_
21-38	4596-4597	,	_
21-39	4598-4599	1	_
21-40	4600-4601	(	_
21-41	4602-4605	one	_
21-42	4606-4611	minor	_
21-43	4612-4618	allele	_
21-44	4619-4620	)	_
21-45	4621-4622	,	_
21-46	4623-4626	and	_
21-47	4627-4628	2	_
21-48	4629-4630	(	_
21-49	4631-4634	two	_
21-50	4635-4640	minor	_
21-51	4641-4648	alleles	_
21-52	4649-4650	)	_
21-53	4651-4652	.	_

Text=Population structure was corrected with PCA.
22-1	4653-4663	Population	_
22-2	4664-4673	structure	_
22-3	4674-4677	was	_
22-4	4678-4687	corrected	_
22-5	4688-4692	with	_
22-6	4693-4696	PCA	_
22-7	4697-4698	.	_

Text=A pre-filtering (i.e., pre-selection) step was conducted leveraging the Psychiatric Genomic Consortium SZ GWAS (Ripke et al., 2014) based on SZ relevance (i.e., the p- values reported by the PGC SZ GWAS).
23-1	4699-4700	A	_
23-2	4701-4714	pre-filtering	_
23-3	4715-4716	(	_
23-4	4717-4721	i.e.	_
23-5	4722-4723	,	_
23-6	4724-4737	pre-selection	_
23-7	4738-4739	)	_
23-8	4740-4744	step	_
23-9	4745-4748	was	_
23-10	4749-4758	conducted	_
23-11	4759-4769	leveraging	_
23-12	4770-4773	the	_
23-13	4774-4785	Psychiatric	_
23-14	4786-4793	Genomic	_
23-15	4794-4804	Consortium	_
23-16	4805-4807	SZ	_
23-17	4808-4812	GWAS	_
23-18	4813-4814	(	_
23-19	4815-4820	Ripke	_
23-20	4821-4823	et	_
23-21	4824-4827	al.	_
23-22	4828-4829	,	_
23-23	4830-4834	2014	_
23-24	4835-4836	)	_
23-25	4837-4842	based	_
23-26	4843-4845	on	_
23-27	4846-4848	SZ	_
23-28	4849-4858	relevance	_
23-29	4859-4860	(	_
23-30	4861-4865	i.e.	_
23-31	4866-4867	,	_
23-32	4868-4871	the	_
23-33	4872-4874	p-	_
23-34	4875-4881	values	_
23-35	4882-4890	reported	_
23-36	4891-4893	by	_
23-37	4894-4897	the	_
23-38	4898-4901	PGC	_
23-39	4902-4904	SZ	_
23-40	4905-4909	GWAS	_
23-41	4910-4911	)	_
23-42	4912-4913	.	_

Text=This resulted in a total of pre-filtered 1546 SNPs, discriminating patients from controls via a univariate SNP-wise test with p-values less than 5× 10−7 in the GWAS.
24-1	4914-4918	This	_
24-2	4919-4927	resulted	_
24-3	4928-4930	in	_
24-4	4931-4932	a	_
24-5	4933-4938	total	_
24-6	4939-4941	of	_
24-7	4942-4954	pre-filtered	_
24-8	4955-4959	1546	_
24-9	4960-4964	SNPs	_
24-10	4965-4966	,	_
24-11	4967-4981	discriminating	_
24-12	4982-4990	patients	_
24-13	4991-4995	from	_
24-14	4996-5004	controls	_
24-15	5005-5008	via	_
24-16	5009-5010	a	_
24-17	5011-5021	univariate	_
24-18	5022-5030	SNP-wise	_
24-19	5031-5035	test	_
24-20	5036-5040	with	_
24-21	5041-5049	p-values	_
24-22	5050-5054	less	_
24-23	5055-5059	than	_
24-24	5060-5062	5×	_
24-25	5063-5067	10−7	_
24-26	5068-5070	in	_
24-27	5071-5074	the	_
24-28	5075-5079	GWAS	_
24-29	5080-5081	.	_

Text=Imaging data processing and feature selection fMRI Data Collection and Preprocessing Imaging data was collected on 3T Siemens Tim Trio Systems (all but one site) or on a 3T General Electric Discovery MR750 scanner.
25-1	5082-5089	Imaging	_
25-2	5090-5094	data	_
25-3	5095-5105	processing	_
25-4	5106-5109	and	_
25-5	5110-5117	feature	_
25-6	5118-5127	selection	_
25-7	5128-5132	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
25-8	5133-5137	Data	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
25-9	5138-5148	Collection	_
25-10	5149-5152	and	_
25-11	5153-5166	Preprocessing	_
25-12	5167-5174	Imaging	_
25-13	5175-5179	data	_
25-14	5180-5183	was	_
25-15	5184-5193	collected	_
25-16	5194-5196	on	_
25-17	5197-5199	3T	_
25-18	5200-5207	Siemens	_
25-19	5208-5211	Tim	_
25-20	5212-5216	Trio	_
25-21	5217-5224	Systems	_
25-22	5225-5226	(	_
25-23	5227-5230	all	_
25-24	5231-5234	but	_
25-25	5235-5238	one	_
25-26	5239-5243	site	_
25-27	5244-5245	)	_
25-28	5246-5248	or	_
25-29	5249-5251	on	_
25-30	5252-5253	a	_
25-31	5254-5256	3T	_
25-32	5257-5264	General	_
25-33	5265-5273	Electric	_
25-34	5274-5283	Discovery	_
25-35	5284-5289	MR750	_
25-36	5290-5297	scanner	_
25-37	5298-5299	.	_

Text=Resting state fMRI scans were acquired using a standard gradient-echo echo planar imaging paradigm: FOV of 220 × 220 mm (64 × 64 matrix), TR = 2 s, TE = 30 ms, FA = 77°, 162 volumes, 32 sequential ascending axial slices of 4 mm thickness and 1 mm skip.
26-1	5300-5307	Resting	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
26-2	5308-5313	state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
26-3	5314-5318	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
26-4	5319-5324	scans	_
26-5	5325-5329	were	_
26-6	5330-5338	acquired	_
26-7	5339-5344	using	_
26-8	5345-5346	a	_
26-9	5347-5355	standard	_
26-10	5356-5369	gradient-echo	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
26-11	5370-5374	echo	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
26-12	5375-5381	planar	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
26-13	5382-5389	imaging	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
26-14	5390-5398	paradigm	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
26-15	5399-5400	:	_
26-16	5401-5404	FOV	_
26-17	5405-5407	of	_
26-18	5408-5411	220	_
26-19	5412-5413	×	_
26-20	5414-5417	220	_
26-21	5418-5420	mm	_
26-22	5421-5422	(	_
26-23	5423-5425	64	_
26-24	5426-5427	×	_
26-25	5428-5430	64	_
26-26	5431-5437	matrix	_
26-27	5438-5439	)	_
26-28	5440-5441	,	_
26-29	5442-5444	TR	_
26-30	5445-5446	=	_
26-31	5447-5448	2	_
26-32	5449-5450	s	_
26-33	5451-5452	,	_
26-34	5453-5455	TE	_
26-35	5456-5457	=	_
26-36	5458-5460	30	_
26-37	5461-5463	ms	_
26-38	5464-5465	,	_
26-39	5466-5468	FA	_
26-40	5469-5470	=	_
26-41	5471-5474	77°	_
26-42	5475-5476	,	_
26-43	5477-5480	162	_
26-44	5481-5488	volumes	_
26-45	5489-5490	,	_
26-46	5491-5493	32	_
26-47	5494-5504	sequential	_
26-48	5505-5514	ascending	_
26-49	5515-5520	axial	_
26-50	5521-5527	slices	_
26-51	5528-5530	of	_
26-52	5531-5532	4	_
26-53	5533-5535	mm	_
26-54	5536-5545	thickness	_
26-55	5546-5549	and	_
26-56	5550-5551	1	_
26-57	5552-5554	mm	_
26-58	5555-5559	skip	_
26-59	5560-5561	.	_

Text=Subjects had their eyes closed during the resting state scan.
27-1	5562-5570	Subjects	_
27-2	5571-5574	had	_
27-3	5575-5580	their	_
27-4	5581-5585	eyes	_
27-5	5586-5592	closed	_
27-6	5593-5599	during	_
27-7	5600-5603	the	_
27-8	5604-5611	resting	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
27-9	5612-5617	state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
27-10	5618-5622	scan	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
27-11	5623-5624	.	_

Text=Data processing was performed using a combination of toolboxes (AFNI, SPM, GIFT) and custom code written in Matlab.
28-1	5625-5629	Data	_
28-2	5630-5640	processing	_
28-3	5641-5644	was	_
28-4	5645-5654	performed	_
28-5	5655-5660	using	_
28-6	5661-5662	a	_
28-7	5663-5674	combination	_
28-8	5675-5677	of	_
28-9	5678-5687	toolboxes	_
28-10	5688-5689	(	_
28-11	5690-5694	AFNI	_
28-12	5695-5696	,	_
28-13	5697-5700	SPM	_
28-14	5701-5702	,	_
28-15	5703-5707	GIFT	_
28-16	5708-5709	)	_
28-17	5710-5713	and	_
28-18	5714-5720	custom	_
28-19	5721-5725	code	_
28-20	5726-5733	written	_
28-21	5734-5736	in	_
28-22	5737-5743	Matlab	_
28-23	5744-5745	.	_

Text=We performed rigid body motion correction using the INRIAlign toolbox in SPM to correct for subject head motion followed by slice-timing correction to account for timing differences in slice acquisition.
29-1	5746-5748	We	_
29-2	5749-5758	performed	_
29-3	5759-5764	rigid	_
29-4	5765-5769	body	_
29-5	5770-5776	motion	_
29-6	5777-5787	correction	_
29-7	5788-5793	using	_
29-8	5794-5797	the	_
29-9	5798-5807	INRIAlign	_
29-10	5808-5815	toolbox	_
29-11	5816-5818	in	_
29-12	5819-5822	SPM	_
29-13	5823-5825	to	_
29-14	5826-5833	correct	_
29-15	5834-5837	for	_
29-16	5838-5845	subject	_
29-17	5846-5850	head	_
29-18	5851-5857	motion	_
29-19	5858-5866	followed	_
29-20	5867-5869	by	_
29-21	5870-5882	slice-timing	_
29-22	5883-5893	correction	_
29-23	5894-5896	to	_
29-24	5897-5904	account	_
29-25	5905-5908	for	_
29-26	5909-5915	timing	_
29-27	5916-5927	differences	_
29-28	5928-5930	in	_
29-29	5931-5936	slice	_
29-30	5937-5948	acquisition	_
29-31	5949-5950	.	_

Text=Then the fMRI data were despiked using AFNI ’ s 3dDespike algorithm to mitigate the impact of outliers.
30-1	5951-5955	Then	_
30-2	5956-5959	the	_
30-3	5960-5964	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
30-4	5965-5969	data	_
30-5	5970-5974	were	_
30-6	5975-5983	despiked	_
30-7	5984-5989	using	_
30-8	5990-5994	AFNI	_
30-9	5995-5996	’	_
30-10	5997-5998	s	_
30-11	5999-6008	3dDespike	_
30-12	6009-6018	algorithm	_
30-13	6019-6021	to	_
30-14	6022-6030	mitigate	_
30-15	6031-6034	the	_
30-16	6035-6041	impact	_
30-17	6042-6044	of	_
30-18	6045-6053	outliers	_
30-19	6054-6055	.	_

Text=The fMRI data were subsequently warped to a Montreal Neurological Institute (MNI) template, and resampled to 3 mm3 isotropic voxels.
31-1	6056-6059	The	_
31-2	6060-6064	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
31-3	6065-6069	data	_
31-4	6070-6074	were	_
31-5	6075-6087	subsequently	_
31-6	6088-6094	warped	_
31-7	6095-6097	to	_
31-8	6098-6099	a	_
31-9	6100-6108	Montreal	_
31-10	6109-6121	Neurological	_
31-11	6122-6131	Institute	_
31-12	6132-6133	(	_
31-13	6134-6137	MNI	_
31-14	6138-6139	)	_
31-15	6140-6148	template	_
31-16	6149-6150	,	_
31-17	6151-6154	and	_
31-18	6155-6164	resampled	_
31-19	6165-6167	to	_
31-20	6168-6169	3	_
31-21	6170-6173	mm3	_
31-22	6174-6183	isotropic	_
31-23	6184-6190	voxels	_
31-24	6191-6192	.	_

Text=Instead of Gaussian smoothing, we smoothed the data to 6 mm full width at half maximum (FWHM) using AFNI3s BlurToFWHM algorithm, which performs smoothing by a conservative finite difference approximation to the diffusion equation.
32-1	6193-6200	Instead	_
32-2	6201-6203	of	_
32-3	6204-6212	Gaussian	_
32-4	6213-6222	smoothing	_
32-5	6223-6224	,	_
32-6	6225-6227	we	_
32-7	6228-6236	smoothed	_
32-8	6237-6240	the	_
32-9	6241-6245	data	_
32-10	6246-6248	to	_
32-11	6249-6250	6	_
32-12	6251-6253	mm	_
32-13	6254-6258	full	_
32-14	6259-6264	width	_
32-15	6265-6267	at	_
32-16	6268-6272	half	_
32-17	6273-6280	maximum	_
32-18	6281-6282	(	_
32-19	6283-6287	FWHM	_
32-20	6288-6289	)	_
32-21	6290-6295	using	_
32-22	6296-6302	AFNI3s	_
32-23	6303-6313	BlurToFWHM	_
32-24	6314-6323	algorithm	_
32-25	6324-6325	,	_
32-26	6326-6331	which	_
32-27	6332-6340	performs	_
32-28	6341-6350	smoothing	_
32-29	6351-6353	by	_
32-30	6354-6355	a	_
32-31	6356-6368	conservative	_
32-32	6369-6375	finite	_
32-33	6376-6386	difference	_
32-34	6387-6400	approximation	_
32-35	6401-6403	to	_
32-36	6404-6407	the	_
32-37	6408-6417	diffusion	_
32-38	6418-6426	equation	_
32-39	6427-6428	.	_

Text=This approach has been shown to reduce scanner specific variability in smoothness providing a “ smoothness equivalence ” to data across sites.
33-1	6429-6433	This	_
33-2	6434-6442	approach	_
33-3	6443-6446	has	_
33-4	6447-6451	been	_
33-5	6452-6457	shown	_
33-6	6458-6460	to	_
33-7	6461-6467	reduce	_
33-8	6468-6475	scanner	_
33-9	6476-6484	specific	_
33-10	6485-6496	variability	_
33-11	6497-6499	in	_
33-12	6500-6510	smoothness	_
33-13	6511-6520	providing	_
33-14	6521-6522	a	_
33-15	6523-6524	“	_
33-16	6525-6535	smoothness	_
33-17	6536-6547	equivalence	_
33-18	6548-6549	”	_
33-19	6550-6552	to	_
33-20	6553-6557	data	_
33-21	6558-6564	across	_
33-22	6565-6570	sites	_
33-23	6571-6572	.	_

Text=Each voxel time course was variance normalized by removing the mean and dividing by the standard deviation at each voxel prior to performing group independent component analysis as this has shown to better decompose subcortical sources in addition to cortical networks.
34-1	6573-6577	Each	_
34-2	6578-6583	voxel	_
34-3	6584-6588	time	_
34-4	6589-6595	course	_
34-5	6596-6599	was	_
34-6	6600-6608	variance	_
34-7	6609-6619	normalized	_
34-8	6620-6622	by	_
34-9	6623-6631	removing	_
34-10	6632-6635	the	_
34-11	6636-6640	mean	_
34-12	6641-6644	and	_
34-13	6645-6653	dividing	_
34-14	6654-6656	by	_
34-15	6657-6660	the	_
34-16	6661-6669	standard	_
34-17	6670-6679	deviation	_
34-18	6680-6682	at	_
34-19	6683-6687	each	_
34-20	6688-6693	voxel	_
34-21	6694-6699	prior	_
34-22	6700-6702	to	_
34-23	6703-6713	performing	_
34-24	6714-6719	group	_
34-25	6720-6731	independent	_
34-26	6732-6741	component	_
34-27	6742-6750	analysis	_
34-28	6751-6753	as	_
34-29	6754-6758	this	_
34-30	6759-6762	has	_
34-31	6763-6768	shown	_
34-32	6769-6771	to	_
34-33	6772-6778	better	_
34-34	6779-6788	decompose	_
34-35	6789-6800	subcortical	_
34-36	6801-6808	sources	_
34-37	6809-6811	in	_
34-38	6812-6820	addition	_
34-39	6821-6823	to	_
34-40	6824-6832	cortical	_
34-41	6833-6841	networks	_
34-42	6842-6843	.	_

Text=Note that, no significant group difference in signal-to-noise ratio (SNR) was found (p=0.5, Figure S4).
35-1	6844-6848	Note	_
35-2	6849-6853	that	_
35-3	6854-6855	,	_
35-4	6856-6858	no	_
35-5	6859-6870	significant	_
35-6	6871-6876	group	_
35-7	6877-6887	difference	_
35-8	6888-6890	in	_
35-9	6891-6906	signal-to-noise	_
35-10	6907-6912	ratio	_
35-11	6913-6914	(	_
35-12	6915-6918	SNR	_
35-13	6919-6920	)	_
35-14	6921-6924	was	_
35-15	6925-6930	found	_
35-16	6931-6932	(	_
35-17	6933-6938	p=0.5	_
35-18	6939-6940	,	_
35-19	6941-6947	Figure	_
35-20	6948-6950	S4	_
35-21	6951-6952	)	_
35-22	6953-6954	.	_

Text=Group ICA, Intrinsic Connectivity Network (ICN) Selection and Post processing After preprocessing the data, functional data from both control and patient groups were analyzed using spatial group independent component analysis (GICA) framework as implemented in the GIFT software.
36-1	6955-6960	Group	_
36-2	6961-6964	ICA	_
36-3	6965-6966	,	_
36-4	6967-6976	Intrinsic	_
36-5	6977-6989	Connectivity	_
36-6	6990-6997	Network	_
36-7	6998-6999	(	_
36-8	7000-7003	ICN	_
36-9	7004-7005	)	_
36-10	7006-7015	Selection	_
36-11	7016-7019	and	_
36-12	7020-7024	Post	_
36-13	7025-7035	processing	_
36-14	7036-7041	After	_
36-15	7042-7055	preprocessing	_
36-16	7056-7059	the	_
36-17	7060-7064	data	_
36-18	7065-7066	,	_
36-19	7067-7077	functional	_
36-20	7078-7082	data	_
36-21	7083-7087	from	_
36-22	7088-7092	both	_
36-23	7093-7100	control	_
36-24	7101-7104	and	_
36-25	7105-7112	patient	_
36-26	7113-7119	groups	_
36-27	7120-7124	were	_
36-28	7125-7133	analyzed	_
36-29	7134-7139	using	_
36-30	7140-7147	spatial	_
36-31	7148-7153	group	_
36-32	7154-7165	independent	_
36-33	7166-7175	component	_
36-34	7176-7184	analysis	_
36-35	7185-7186	(	_
36-36	7187-7191	GICA	_
36-37	7192-7193	)	_
36-38	7194-7203	framework	_
36-39	7204-7206	as	_
36-40	7207-7218	implemented	_
36-41	7219-7221	in	_
36-42	7222-7225	the	_
36-43	7226-7230	GIFT	_
36-44	7231-7239	software	_
36-45	7240-7241	.	_

Text=Spatial ICA decomposes the subject data into linear mixtures of spatially independent components that exhibit a unique time course profile.
37-1	7242-7249	Spatial	_
37-2	7250-7253	ICA	_
37-3	7254-7264	decomposes	_
37-4	7265-7268	the	_
37-5	7269-7276	subject	_
37-6	7277-7281	data	_
37-7	7282-7286	into	_
37-8	7287-7293	linear	_
37-9	7294-7302	mixtures	_
37-10	7303-7305	of	_
37-11	7306-7315	spatially	_
37-12	7316-7327	independent	_
37-13	7328-7338	components	_
37-14	7339-7343	that	_
37-15	7344-7351	exhibit	_
37-16	7352-7353	a	_
37-17	7354-7360	unique	_
37-18	7361-7365	time	_
37-19	7366-7372	course	_
37-20	7373-7380	profile	_
37-21	7381-7382	.	_

Text=A subject- specific data reduction step was first used to reduce 162 time point data into 120 direction of maximal variability using principal component analysis.
38-1	7383-7384	A	_
38-2	7385-7393	subject-	_
38-3	7394-7402	specific	_
38-4	7403-7407	data	_
38-5	7408-7417	reduction	_
38-6	7418-7422	step	_
38-7	7423-7426	was	_
38-8	7427-7432	first	_
38-9	7433-7437	used	_
38-10	7438-7440	to	_
38-11	7441-7447	reduce	_
38-12	7448-7451	162	_
38-13	7452-7456	time	_
38-14	7457-7462	point	_
38-15	7463-7467	data	_
38-16	7468-7472	into	_
38-17	7473-7476	120	_
38-18	7477-7486	direction	_
38-19	7487-7489	of	_
38-20	7490-7497	maximal	_
38-21	7498-7509	variability	_
38-22	7510-7515	using	_
38-23	7516-7525	principal	_
38-24	7526-7535	component	_
38-25	7536-7544	analysis	_
38-26	7545-7546	.	_

Text=Then subject-reduced data were concatenated across time and a group data PCA step reduced this matrix further into 100 components along directions of maximal group variability.
39-1	7547-7551	Then	_
39-2	7552-7567	subject-reduced	_
39-3	7568-7572	data	_
39-4	7573-7577	were	_
39-5	7578-7590	concatenated	_
39-6	7591-7597	across	_
39-7	7598-7602	time	_
39-8	7603-7606	and	_
39-9	7607-7608	a	_
39-10	7609-7614	group	_
39-11	7615-7619	data	_
39-12	7620-7623	PCA	_
39-13	7624-7628	step	_
39-14	7629-7636	reduced	_
39-15	7637-7641	this	_
39-16	7642-7648	matrix	_
39-17	7649-7656	further	_
39-18	7657-7661	into	_
39-19	7662-7665	100	_
39-20	7666-7676	components	_
39-21	7677-7682	along	_
39-22	7683-7693	directions	_
39-23	7694-7696	of	_
39-24	7697-7704	maximal	_
39-25	7705-7710	group	_
39-26	7711-7722	variability	_
39-27	7723-7724	.	_

Text=Note that, group PCA on the entire dataset was performed to avoid biasing the solution to group differences.
40-1	7725-7729	Note	_
40-2	7730-7734	that	_
40-3	7735-7736	,	_
40-4	7737-7742	group	_
40-5	7743-7746	PCA	_
40-6	7747-7749	on	_
40-7	7750-7753	the	_
40-8	7754-7760	entire	_
40-9	7761-7768	dataset	_
40-10	7769-7772	was	_
40-11	7773-7782	performed	_
40-12	7783-7785	to	_
40-13	7786-7791	avoid	_
40-14	7792-7799	biasing	_
40-15	7800-7803	the	_
40-16	7804-7812	solution	_
40-17	7813-7815	to	_
40-18	7816-7821	group	_
40-19	7822-7833	differences	_
40-20	7834-7835	.	_

Text=One hundred independent components were obtained from the group PCA reduced matrix using the infomax algorithm.
41-1	7836-7839	One	_
41-2	7840-7847	hundred	_
41-3	7848-7859	independent	_
41-4	7860-7870	components	_
41-5	7871-7875	were	_
41-6	7876-7884	obtained	_
41-7	7885-7889	from	_
41-8	7890-7893	the	_
41-9	7894-7899	group	_
41-10	7900-7903	PCA	_
41-11	7904-7911	reduced	_
41-12	7912-7918	matrix	_
41-13	7919-7924	using	_
41-14	7925-7928	the	_
41-15	7929-7936	infomax	_
41-16	7937-7946	algorithm	_
41-17	7947-7948	.	_

Text=To ensure stability of estimation, we repeated the ICA algorithm 20 times in ICASSO, and aggregate spatial maps were estimated as the modes of component clusters.
42-1	7949-7951	To	_
42-2	7952-7958	ensure	_
42-3	7959-7968	stability	_
42-4	7969-7971	of	_
42-5	7972-7982	estimation	_
42-6	7983-7984	,	_
42-7	7985-7987	we	_
42-8	7988-7996	repeated	_
42-9	7997-8000	the	_
42-10	8001-8004	ICA	_
42-11	8005-8014	algorithm	_
42-12	8015-8017	20	_
42-13	8018-8023	times	_
42-14	8024-8026	in	_
42-15	8027-8033	ICASSO	_
42-16	8034-8035	,	_
42-17	8036-8039	and	_
42-18	8040-8049	aggregate	_
42-19	8050-8057	spatial	_
42-20	8058-8062	maps	_
42-21	8063-8067	were	_
42-22	8068-8077	estimated	_
42-23	8078-8080	as	_
42-24	8081-8084	the	_
42-25	8085-8090	modes	_
42-26	8091-8093	of	_
42-27	8094-8103	component	_
42-28	8104-8112	clusters	_
42-29	8113-8114	.	_

Text=Subject specific spatial maps (SMs) and time courses (TCs) were obtained using the spatiotemporal regression back reconstruction approach implemented in the GIFT software.
43-1	8115-8122	Subject	_
43-2	8123-8131	specific	_
43-3	8132-8139	spatial	_
43-4	8140-8144	maps	_
43-5	8145-8146	(	_
43-6	8147-8150	SMs	_
43-7	8151-8152	)	_
43-8	8153-8156	and	_
43-9	8157-8161	time	_
43-10	8162-8169	courses	_
43-11	8170-8171	(	_
43-12	8172-8175	TCs	_
43-13	8176-8177	)	_
43-14	8178-8182	were	_
43-15	8183-8191	obtained	_
43-16	8192-8197	using	_
43-17	8198-8201	the	_
43-18	8202-8216	spatiotemporal	_
43-19	8217-8227	regression	_
43-20	8228-8232	back	_
43-21	8233-8247	reconstruction	_
43-22	8248-8256	approach	_
43-23	8257-8268	implemented	_
43-24	8269-8271	in	_
43-25	8272-8275	the	_
43-26	8276-8280	GIFT	_
43-27	8281-8289	software	_
43-28	8290-8291	.	_

Text=Subject specific SMs and TCs underwent post-processing as described in our earlier work (Allen et al., 2012).
44-1	8292-8299	Subject	_
44-2	8300-8308	specific	_
44-3	8309-8312	SMs	_
44-4	8313-8316	and	_
44-5	8317-8320	TCs	_
44-6	8321-8330	underwent	_
44-7	8331-8346	post-processing	_
44-8	8347-8349	as	_
44-9	8350-8359	described	_
44-10	8360-8362	in	_
44-11	8363-8366	our	_
44-12	8367-8374	earlier	_
44-13	8375-8379	work	_
44-14	8380-8381	(	_
44-15	8382-8387	Allen	_
44-16	8388-8390	et	_
44-17	8391-8394	al.	_
44-18	8395-8396	,	_
44-19	8397-8401	2012	_
44-20	8402-8403	)	_
44-21	8404-8405	.	_

Text=Briefly, we obtained one sample t-test maps for each SM across all subjects and thresholded these maps to obtain regions of peak activation clusters for that component; we also computed mean power spectra of the corresponding TCs.
45-1	8406-8413	Briefly	_
45-2	8414-8415	,	_
45-3	8416-8418	we	_
45-4	8419-8427	obtained	_
45-5	8428-8431	one	_
45-6	8432-8438	sample	_
45-7	8439-8445	t-test	_
45-8	8446-8450	maps	_
45-9	8451-8454	for	_
45-10	8455-8459	each	_
45-11	8460-8462	SM	_
45-12	8463-8469	across	_
45-13	8470-8473	all	_
45-14	8474-8482	subjects	_
45-15	8483-8486	and	_
45-16	8487-8498	thresholded	_
45-17	8499-8504	these	_
45-18	8505-8509	maps	_
45-19	8510-8512	to	_
45-20	8513-8519	obtain	_
45-21	8520-8527	regions	_
45-22	8528-8530	of	_
45-23	8531-8535	peak	_
45-24	8536-8546	activation	_
45-25	8547-8555	clusters	_
45-26	8556-8559	for	_
45-27	8560-8564	that	_
45-28	8565-8574	component	_
45-29	8575-8576	;	_
45-30	8577-8579	we	_
45-31	8580-8584	also	_
45-32	8585-8593	computed	_
45-33	8594-8598	mean	_
45-34	8599-8604	power	_
45-35	8605-8612	spectra	_
45-36	8613-8615	of	_
45-37	8616-8619	the	_
45-38	8620-8633	corresponding	_
45-39	8634-8637	TCs	_
45-40	8638-8639	.	_

Text=We visually inspected and identified a set of components as intrinsic connectivity networks (ICNs) if their peak activation clusters fell on GM (gray matter) and showed less overlap with known vascular, susceptibility, ventricular, and edge regions corresponding to head motion.
46-1	8640-8642	We	_
46-2	8643-8651	visually	_
46-3	8652-8661	inspected	_
46-4	8662-8665	and	_
46-5	8666-8676	identified	_
46-6	8677-8678	a	_
46-7	8679-8682	set	_
46-8	8683-8685	of	_
46-9	8686-8696	components	_
46-10	8697-8699	as	_
46-11	8700-8709	intrinsic	_
46-12	8710-8722	connectivity	_
46-13	8723-8731	networks	_
46-14	8732-8733	(	_
46-15	8734-8738	ICNs	_
46-16	8739-8740	)	_
46-17	8741-8743	if	_
46-18	8744-8749	their	_
46-19	8750-8754	peak	_
46-20	8755-8765	activation	_
46-21	8766-8774	clusters	_
46-22	8775-8779	fell	_
46-23	8780-8782	on	_
46-24	8783-8785	GM	_
46-25	8786-8787	(	_
46-26	8788-8792	gray	_
46-27	8793-8799	matter	_
46-28	8800-8801	)	_
46-29	8802-8805	and	_
46-30	8806-8812	showed	_
46-31	8813-8817	less	_
46-32	8818-8825	overlap	_
46-33	8826-8830	with	_
46-34	8831-8836	known	_
46-35	8837-8845	vascular	_
46-36	8846-8847	,	_
46-37	8848-8862	susceptibility	_
46-38	8863-8864	,	_
46-39	8865-8876	ventricular	_
46-40	8877-8878	,	_
46-41	8879-8882	and	_
46-42	8883-8887	edge	_
46-43	8888-8895	regions	_
46-44	8896-8909	corresponding	_
46-45	8910-8912	to	_
46-46	8913-8917	head	_
46-47	8918-8924	motion	_
46-48	8925-8926	.	_

Text=We also ensured that the mean power spectra of the selected ICN time courses showed higher low frequency spectral power.
47-1	8927-8929	We	_
47-2	8930-8934	also	_
47-3	8935-8942	ensured	_
47-4	8943-8947	that	_
47-5	8948-8951	the	_
47-6	8952-8956	mean	_
47-7	8957-8962	power	_
47-8	8963-8970	spectra	_
47-9	8971-8973	of	_
47-10	8974-8977	the	_
47-11	8978-8986	selected	_
47-12	8987-8990	ICN	_
47-13	8991-8995	time	_
47-14	8996-9003	courses	_
47-15	9004-9010	showed	_
47-16	9011-9017	higher	_
47-17	9018-9021	low	_
47-18	9022-9031	frequency	_
47-19	9032-9040	spectral	_
47-20	9041-9046	power	_
47-21	9047-9048	.	_

Text=This selection procedure resulted in 47 ICNs out of the 100 independent components obtained.
48-1	9049-9053	This	_
48-2	9054-9063	selection	_
48-3	9064-9073	procedure	_
48-4	9074-9082	resulted	_
48-5	9083-9085	in	_
48-6	9086-9088	47	_
48-7	9089-9093	ICNs	_
48-8	9094-9097	out	_
48-9	9098-9100	of	_
48-10	9101-9104	the	_
48-11	9105-9108	100	_
48-12	9109-9120	independent	_
48-13	9121-9131	components	_
48-14	9132-9140	obtained	_
48-15	9141-9142	.	_

Text=The ICNs were assessed and distributed into sub-cortical (SC), auditory (AUD), visual (VIS), sensorimotor (SM), attention/cognitive control (CC), default-mode (DMN), and cerebellar (CB) network domains.
49-1	9143-9146	The	_
49-2	9147-9151	ICNs	_
49-3	9152-9156	were	_
49-4	9157-9165	assessed	_
49-5	9166-9169	and	_
49-6	9170-9181	distributed	_
49-7	9182-9186	into	_
49-8	9187-9199	sub-cortical	_
49-9	9200-9201	(	_
49-10	9202-9204	SC	_
49-11	9205-9206	)	_
49-12	9207-9208	,	_
49-13	9209-9217	auditory	_
49-14	9218-9219	(	_
49-15	9220-9223	AUD	_
49-16	9224-9225	)	_
49-17	9226-9227	,	_
49-18	9228-9234	visual	_
49-19	9235-9236	(	_
49-20	9237-9240	VIS	_
49-21	9241-9242	)	_
49-22	9243-9244	,	_
49-23	9245-9257	sensorimotor	_
49-24	9258-9259	(	_
49-25	9260-9262	SM	_
49-26	9263-9264	)	_
49-27	9265-9266	,	_
49-28	9267-9286	attention/cognitive	_
49-29	9287-9294	control	_
49-30	9295-9296	(	_
49-31	9297-9299	CC	_
49-32	9300-9301	)	_
49-33	9302-9303	,	_
49-34	9304-9316	default-mode	_
49-35	9317-9318	(	_
49-36	9319-9322	DMN	_
49-37	9323-9324	)	_
49-38	9325-9326	,	_
49-39	9327-9330	and	_
49-40	9331-9341	cerebellar	_
49-41	9342-9343	(	_
49-42	9344-9346	CB	_
49-43	9347-9348	)	_
49-44	9349-9356	network	_
49-45	9357-9364	domains	_
49-46	9365-9366	.	_

Text=Subject-specific TCs corresponding to the retained ICNs underwent additional post processing steps.
50-1	9367-9383	Subject-specific	_
50-2	9384-9387	TCs	_
50-3	9388-9401	corresponding	_
50-4	9402-9404	to	_
50-5	9405-9408	the	_
50-6	9409-9417	retained	_
50-7	9418-9422	ICNs	_
50-8	9423-9432	underwent	_
50-9	9433-9443	additional	_
50-10	9444-9448	post	_
50-11	9449-9459	processing	_
50-12	9460-9465	steps	_
50-13	9466-9467	.	_

Text=The TCs were detrended to remove any existing linear, quadratic or cubic low frequency trends originating from scanner drift, orthogonalized with respect to estimated subject motion and realignment parameters, and despiked using AFNI ’ s 3dDespike function to replace outlier points with values estimated from third order spline fit to neighboring portions of the TCs.
51-1	9468-9471	The	_
51-2	9472-9475	TCs	_
51-3	9476-9480	were	_
51-4	9481-9490	detrended	_
51-5	9491-9493	to	_
51-6	9494-9500	remove	_
51-7	9501-9504	any	_
51-8	9505-9513	existing	_
51-9	9514-9520	linear	_
51-10	9521-9522	,	_
51-11	9523-9532	quadratic	_
51-12	9533-9535	or	_
51-13	9536-9541	cubic	_
51-14	9542-9545	low	_
51-15	9546-9555	frequency	_
51-16	9556-9562	trends	_
51-17	9563-9574	originating	_
51-18	9575-9579	from	_
51-19	9580-9587	scanner	_
51-20	9588-9593	drift	_
51-21	9594-9595	,	_
51-22	9596-9610	orthogonalized	_
51-23	9611-9615	with	_
51-24	9616-9623	respect	_
51-25	9624-9626	to	_
51-26	9627-9636	estimated	_
51-27	9637-9644	subject	_
51-28	9645-9651	motion	_
51-29	9652-9655	and	_
51-30	9656-9667	realignment	_
51-31	9668-9678	parameters	_
51-32	9679-9680	,	_
51-33	9681-9684	and	_
51-34	9685-9693	despiked	_
51-35	9694-9699	using	_
51-36	9700-9704	AFNI	_
51-37	9705-9706	’	_
51-38	9707-9708	s	_
51-39	9709-9718	3dDespike	_
51-40	9719-9727	function	_
51-41	9728-9730	to	_
51-42	9731-9738	replace	_
51-43	9739-9746	outlier	_
51-44	9747-9753	points	_
51-45	9754-9758	with	_
51-46	9759-9765	values	_
51-47	9766-9775	estimated	_
51-48	9776-9780	from	_
51-49	9781-9786	third	_
51-50	9787-9792	order	_
51-51	9793-9799	spline	_
51-52	9800-9803	fit	_
51-53	9804-9806	to	_
51-54	9807-9818	neighboring	_
51-55	9819-9827	portions	_
51-56	9828-9830	of	_
51-57	9831-9834	the	_
51-58	9835-9838	TCs	_
51-59	9839-9840	.	_

Text=FC Estimation and Clustering Similar to our previous work time-varying FNC was estimated by sliding a window of length 22 TRs (44 s) in steps of 1 TR (2 s).
52-1	9841-9843	FC	_
52-2	9844-9854	Estimation	_
52-3	9855-9858	and	_
52-4	9859-9869	Clustering	_
52-5	9870-9877	Similar	_
52-6	9878-9880	to	_
52-7	9881-9884	our	_
52-8	9885-9893	previous	_
52-9	9894-9898	work	_
52-10	9899-9911	time-varying	_
52-11	9912-9915	FNC	_
52-12	9916-9919	was	_
52-13	9920-9929	estimated	_
52-14	9930-9932	by	_
52-15	9933-9940	sliding	_
52-16	9941-9942	a	_
52-17	9943-9949	window	_
52-18	9950-9952	of	_
52-19	9953-9959	length	_
52-20	9960-9962	22	_
52-21	9963-9966	TRs	_
52-22	9967-9968	(	_
52-23	9969-9971	44	_
52-24	9972-9973	s	_
52-25	9974-9975	)	_
52-26	9976-9978	in	_
52-27	9979-9984	steps	_
52-28	9985-9987	of	_
52-29	9988-9989	1	_
52-30	9990-9992	TR	_
52-31	9993-9994	(	_
52-32	9995-9996	2	_
52-33	9997-9998	s	_
52-34	9999-10000	)	_
52-35	10001-10002	.	_

Text=This sliding window analysis used a tapered window generated by convolving a rectangular window of length 22 TRs (44 s) with a Gaussian window of standard deviation equal to 3 TRs.
53-1	10003-10007	This	_
53-2	10008-10015	sliding	_
53-3	10016-10022	window	_
53-4	10023-10031	analysis	_
53-5	10032-10036	used	_
53-6	10037-10038	a	_
53-7	10039-10046	tapered	_
53-8	10047-10053	window	_
53-9	10054-10063	generated	_
53-10	10064-10066	by	_
53-11	10067-10077	convolving	_
53-12	10078-10079	a	_
53-13	10080-10091	rectangular	_
53-14	10092-10098	window	_
53-15	10099-10101	of	_
53-16	10102-10108	length	_
53-17	10109-10111	22	_
53-18	10112-10115	TRs	_
53-19	10116-10117	(	_
53-20	10118-10120	44	_
53-21	10121-10122	s	_
53-22	10123-10124	)	_
53-23	10125-10129	with	_
53-24	10130-10131	a	_
53-25	10132-10140	Gaussian	_
53-26	10141-10147	window	_
53-27	10148-10150	of	_
53-28	10151-10159	standard	_
53-29	10160-10169	deviation	_
53-30	10170-10175	equal	_
53-31	10176-10178	to	_
53-32	10179-10180	3	_
53-33	10181-10184	TRs	_
53-34	10185-10186	.	_

Text=To characterize the full covariance matrix, we estimated covariance from the regularized precision matrix or the inverse covariance matrix.
54-1	10187-10189	To	_
54-2	10190-10202	characterize	_
54-3	10203-10206	the	_
54-4	10207-10211	full	_
54-5	10212-10222	covariance	_
54-6	10223-10229	matrix	_
54-7	10230-10231	,	_
54-8	10232-10234	we	_
54-9	10235-10244	estimated	_
54-10	10245-10255	covariance	_
54-11	10256-10260	from	_
54-12	10261-10264	the	_
54-13	10265-10276	regularized	_
54-14	10277-10286	precision	_
54-15	10287-10293	matrix	_
54-16	10294-10296	or	_
54-17	10297-10300	the	_
54-18	10301-10308	inverse	_
54-19	10309-10319	covariance	_
54-20	10320-10326	matrix	_
54-21	10327-10328	.	_

Text=Following the graphical LASSO method, we placed a penalty on the L1 norm of the precision matrix to promote sparsity.
55-1	10329-10338	Following	_
55-2	10339-10342	the	_
55-3	10343-10352	graphical	_
55-4	10353-10358	LASSO	_
55-5	10359-10365	method	_
55-6	10366-10367	,	_
55-7	10368-10370	we	_
55-8	10371-10377	placed	_
55-9	10378-10379	a	_
55-10	10380-10387	penalty	_
55-11	10388-10390	on	_
55-12	10391-10394	the	_
55-13	10395-10397	L1	_
55-14	10398-10402	norm	_
55-15	10403-10405	of	_
55-16	10406-10409	the	_
55-17	10410-10419	precision	_
55-18	10420-10426	matrix	_
55-19	10427-10429	to	_
55-20	10430-10437	promote	_
55-21	10438-10446	sparsity	_
55-22	10447-10448	.	_

Text=The regularization parameter lambda was optimized separately for each subject by evaluating the log-likelihood of unseen data (windowed covariance matrices from the same subject) in a cross-validation framework.
56-1	10449-10452	The	_
56-2	10453-10467	regularization	_
56-3	10468-10477	parameter	_
56-4	10478-10484	lambda	_
56-5	10485-10488	was	_
56-6	10489-10498	optimized	_
56-7	10499-10509	separately	_
56-8	10510-10513	for	_
56-9	10514-10518	each	_
56-10	10519-10526	subject	_
56-11	10527-10529	by	_
56-12	10530-10540	evaluating	_
56-13	10541-10544	the	_
56-14	10545-10559	log-likelihood	_
56-15	10560-10562	of	_
56-16	10563-10569	unseen	_
56-17	10570-10574	data	_
56-18	10575-10576	(	_
56-19	10577-10585	windowed	_
56-20	10586-10596	covariance	_
56-21	10597-10605	matrices	_
56-22	10606-10610	from	_
56-23	10611-10614	the	_
56-24	10615-10619	same	_
56-25	10620-10627	subject	_
56-26	10628-10629	)	_
56-27	10630-10632	in	_
56-28	10633-10634	a	_
56-29	10635-10651	cross-validation	_
56-30	10652-10661	framework	_
56-31	10662-10663	.	_

Text=Final dynamic FC estimates for each window, were concatenated to form a C x C x W array representing the changes in covariance (correlation) between components as a function of time.
57-1	10664-10669	Final	_
57-2	10670-10677	dynamic	_
57-3	10678-10680	FC	_
57-4	10681-10690	estimates	_
57-5	10691-10694	for	_
57-6	10695-10699	each	_
57-7	10700-10706	window	_
57-8	10707-10708	,	_
57-9	10709-10713	were	_
57-10	10714-10726	concatenated	_
57-11	10727-10729	to	_
57-12	10730-10734	form	_
57-13	10735-10736	a	_
57-14	10737-10738	C	_
57-15	10739-10740	x	_
57-16	10741-10742	C	_
57-17	10743-10744	x	_
57-18	10745-10746	W	_
57-19	10747-10752	array	_
57-20	10753-10765	representing	_
57-21	10766-10769	the	_
57-22	10770-10777	changes	_
57-23	10778-10780	in	_
57-24	10781-10791	covariance	_
57-25	10792-10793	(	_
57-26	10794-10805	correlation	_
57-27	10806-10807	)	_
57-28	10808-10815	between	_
57-29	10816-10826	components	_
57-30	10827-10829	as	_
57-31	10830-10831	a	_
57-32	10832-10840	function	_
57-33	10841-10843	of	_
57-34	10844-10848	time	_
57-35	10849-10850	.	_

Text=Next, we selected windows of higher variability as subject exemplars and used K-means clustering to obtain group centroids.
58-1	10851-10855	Next	_
58-2	10856-10857	,	_
58-3	10858-10860	we	_
58-4	10861-10869	selected	_
58-5	10870-10877	windows	_
58-6	10878-10880	of	_
58-7	10881-10887	higher	_
58-8	10888-10899	variability	_
58-9	10900-10902	as	_
58-10	10903-10910	subject	_
58-11	10911-10920	exemplars	_
58-12	10921-10924	and	_
58-13	10925-10929	used	_
58-14	10930-10937	K-means	_
58-15	10938-10948	clustering	_
58-16	10949-10951	to	_
58-17	10952-10958	obtain	_
58-18	10959-10964	group	_
58-19	10965-10974	centroids	_
58-20	10975-10976	.	_

Text=We determined the number of clusters to be five using the elbow criterion of the cluster validity index, which is computed as the ratio between within-cluster distances to between-cluster distance.
59-1	10977-10979	We	_
59-2	10980-10990	determined	_
59-3	10991-10994	the	_
59-4	10995-11001	number	_
59-5	11002-11004	of	_
59-6	11005-11013	clusters	_
59-7	11014-11016	to	_
59-8	11017-11019	be	_
59-9	11020-11024	five	_
59-10	11025-11030	using	_
59-11	11031-11034	the	_
59-12	11035-11040	elbow	_
59-13	11041-11050	criterion	_
59-14	11051-11053	of	_
59-15	11054-11057	the	_
59-16	11058-11065	cluster	_
59-17	11066-11074	validity	_
59-18	11075-11080	index	_
59-19	11081-11082	,	_
59-20	11083-11088	which	_
59-21	11089-11091	is	_
59-22	11092-11100	computed	_
59-23	11101-11103	as	_
59-24	11104-11107	the	_
59-25	11108-11113	ratio	_
59-26	11114-11121	between	_
59-27	11122-11136	within-cluster	_
59-28	11137-11146	distances	_
59-29	11147-11149	to	_
59-30	11150-11165	between-cluster	_
59-31	11166-11174	distance	_
59-32	11175-11176	.	_

Text=These centroids are then used as starting points to cluster all of the dynamic FNC data.
60-1	11177-11182	These	_
60-2	11183-11192	centroids	_
60-3	11193-11196	are	_
60-4	11197-11201	then	_
60-5	11202-11206	used	_
60-6	11207-11209	as	_
60-7	11210-11218	starting	_
60-8	11219-11225	points	_
60-9	11226-11228	to	_
60-10	11229-11236	cluster	_
60-11	11237-11240	all	_
60-12	11241-11243	of	_
60-13	11244-11247	the	_
60-14	11248-11255	dynamic	_
60-15	11256-11259	FNC	_
60-16	11260-11264	data	_
60-17	11265-11266	.	_

Text=Group- and subject- specific centroids were computed for further analyses.
61-1	11267-11273	Group-	_
61-2	11274-11277	and	_
61-3	11278-11286	subject-	_
61-4	11287-11295	specific	_
61-5	11296-11305	centroids	_
61-6	11306-11310	were	_
61-7	11311-11319	computed	_
61-8	11320-11323	for	_
61-9	11324-11331	further	_
61-10	11332-11340	analyses	_
61-11	11341-11342	.	_

Text=Proposed pICA framework Figure 1 and Figure S5 provides an illustration of the proposed framework.
62-1	11343-11351	Proposed	_
62-2	11352-11356	pICA	_
62-3	11357-11366	framework	_
62-4	11367-11373	Figure	_
62-5	11374-11375	1	_
62-6	11376-11379	and	_
62-7	11380-11386	Figure	_
62-8	11387-11389	S5	_
62-9	11390-11398	provides	_
62-10	11399-11401	an	_
62-11	11402-11414	illustration	_
62-12	11415-11417	of	_
62-13	11418-11421	the	_
62-14	11422-11430	proposed	_
62-15	11431-11440	framework	_
62-16	11441-11442	.	_

Text=pICA was performed through the Fusion ICA Toolbox (FIT, http: //mialab.mrn.org/software/fit) using the imaging (dynamic states) and genomic (SNP array) features.
63-1	11443-11447	pICA	_
63-2	11448-11451	was	_
63-3	11452-11461	performed	_
63-4	11462-11469	through	_
63-5	11470-11473	the	_
63-6	11474-11480	Fusion	_
63-7	11481-11484	ICA	_
63-8	11485-11492	Toolbox	_
63-9	11493-11494	(	_
63-10	11495-11498	FIT	_
63-11	11499-11500	,	_
63-12	11501-11505	http	_
63-13	11506-11507	:	_
63-14	11508-11537	//mialab.mrn.org/software/fit	_
63-15	11538-11539	)	_
63-16	11540-11545	using	_
63-17	11546-11549	the	_
63-18	11550-11557	imaging	_
63-19	11558-11559	(	_
63-20	11560-11567	dynamic	_
63-21	11568-11574	states	_
63-22	11575-11576	)	_
63-23	11577-11580	and	_
63-24	11581-11588	genomic	_
63-25	11589-11590	(	_
63-26	11591-11594	SNP	_
63-27	11595-11600	array	_
63-28	11601-11602	)	_
63-29	11603-11611	features	_
63-30	11612-11613	.	_

Text=The algorithm was configured with a threshold of 0.25 for constrained correlations to avoid false positive associations and to only constrain one pair of components.
64-1	11614-11617	The	_
64-2	11618-11627	algorithm	_
64-3	11628-11631	was	_
64-4	11632-11642	configured	_
64-5	11643-11647	with	_
64-6	11648-11649	a	_
64-7	11650-11659	threshold	_
64-8	11660-11662	of	_
64-9	11663-11667	0.25	_
64-10	11668-11671	for	_
64-11	11672-11683	constrained	_
64-12	11684-11696	correlations	_
64-13	11697-11699	to	_
64-14	11700-11705	avoid	_
64-15	11706-11711	false	_
64-16	11712-11720	positive	_
64-17	11721-11733	associations	_
64-18	11734-11737	and	_
64-19	11738-11740	to	_
64-20	11741-11745	only	_
64-21	11746-11755	constrain	_
64-22	11756-11759	one	_
64-23	11760-11764	pair	_
64-24	11765-11767	of	_
64-25	11768-11778	components	_
64-26	11779-11780	.	_

Text=A SNP component is defined by large clusters of functionally related SNPs statistically correlated with phenotype components, whereas a dFNC component is defined by clusters of related connectivity links among distant brain regions distributed across 5 discrete dynamic states, and statistically correlated with genomic components (Table S2).
65-1	11781-11782	A	_
65-2	11783-11786	SNP	_
65-3	11787-11796	component	_
65-4	11797-11799	is	_
65-5	11800-11807	defined	_
65-6	11808-11810	by	_
65-7	11811-11816	large	_
65-8	11817-11825	clusters	_
65-9	11826-11828	of	_
65-10	11829-11841	functionally	_
65-11	11842-11849	related	_
65-12	11850-11854	SNPs	_
65-13	11855-11868	statistically	_
65-14	11869-11879	correlated	_
65-15	11880-11884	with	_
65-16	11885-11894	phenotype	_
65-17	11895-11905	components	_
65-18	11906-11907	,	_
65-19	11908-11915	whereas	_
65-20	11916-11917	a	_
65-21	11918-11922	dFNC	_
65-22	11923-11932	component	_
65-23	11933-11935	is	_
65-24	11936-11943	defined	_
65-25	11944-11946	by	_
65-26	11947-11955	clusters	_
65-27	11956-11958	of	_
65-28	11959-11966	related	_
65-29	11967-11979	connectivity	_
65-30	11980-11985	links	_
65-31	11986-11991	among	_
65-32	11992-11999	distant	_
65-33	12000-12005	brain	_
65-34	12006-12013	regions	_
65-35	12014-12025	distributed	_
65-36	12026-12032	across	_
65-37	12033-12034	5	_
65-38	12035-12043	discrete	_
65-39	12044-12051	dynamic	_
65-40	12052-12058	states	_
65-41	12059-12060	,	_
65-42	12061-12064	and	_
65-43	12065-12078	statistically	_
65-44	12079-12089	correlated	_
65-45	12090-12094	with	_
65-46	12095-12102	genomic	_
65-47	12103-12113	components	_
65-48	12114-12115	(	_
65-49	12116-12121	Table	_
65-50	12122-12124	S2	_
65-51	12125-12126	)	_
65-52	12127-12128	.	_

Text=An endurance parameter was set to −5 × 10−4 to control the decreasing slope of the entropy term and to mitigate against over fitting.
66-1	12129-12131	An	_
66-2	12132-12141	endurance	_
66-3	12142-12151	parameter	_
66-4	12152-12155	was	_
66-5	12156-12159	set	_
66-6	12160-12162	to	_
66-7	12163-12165	−5	_
66-8	12166-12167	×	_
66-9	12168-12172	10−4	_
66-10	12173-12175	to	_
66-11	12176-12183	control	_
66-12	12184-12187	the	_
66-13	12188-12198	decreasing	_
66-14	12199-12204	slope	_
66-15	12205-12207	of	_
66-16	12208-12211	the	_
66-17	12212-12219	entropy	_
66-18	12220-12224	term	_
66-19	12225-12228	and	_
66-20	12229-12231	to	_
66-21	12232-12240	mitigate	_
66-22	12241-12248	against	_
66-23	12249-12253	over	_
66-24	12254-12261	fitting	_
66-25	12262-12263	.	_

Text=For the fMRI modality (dFNC features), the component number was predefined as 15, and for genomic modality (SNP data) the component number was predefined as 25 based on pICA model stability, which was validated using the permutation test.
67-1	12264-12267	For	_
67-2	12268-12271	the	_
67-3	12272-12276	fMRI	_
67-4	12277-12285	modality	_
67-5	12286-12287	(	_
67-6	12288-12292	dFNC	_
67-7	12293-12301	features	_
67-8	12302-12303	)	_
67-9	12304-12305	,	_
67-10	12306-12309	the	_
67-11	12310-12319	component	_
67-12	12320-12326	number	_
67-13	12327-12330	was	_
67-14	12331-12341	predefined	_
67-15	12342-12344	as	_
67-16	12345-12347	15	_
67-17	12348-12349	,	_
67-18	12350-12353	and	_
67-19	12354-12357	for	_
67-20	12358-12365	genomic	_
67-21	12366-12374	modality	_
67-22	12375-12376	(	_
67-23	12377-12380	SNP	_
67-24	12381-12385	data	_
67-25	12386-12387	)	_
67-26	12388-12391	the	_
67-27	12392-12401	component	_
67-28	12402-12408	number	_
67-29	12409-12412	was	_
67-30	12413-12423	predefined	_
67-31	12424-12426	as	_
67-32	12427-12429	25	_
67-33	12430-12435	based	_
67-34	12436-12438	on	_
67-35	12439-12443	pICA	_
67-36	12444-12449	model	_
67-37	12450-12459	stability	_
67-38	12460-12461	,	_
67-39	12462-12467	which	_
67-40	12468-12471	was	_
67-41	12472-12481	validated	_
67-42	12482-12487	using	_
67-43	12488-12491	the	_
67-44	12492-12503	permutation	_
67-45	12504-12508	test	_
67-46	12509-12510	.	_

Text=The parallel ICA estimates components by maximizing component independence within each data modality, and maximizing the inter-modality association assessed based on component loadings from the two modalities.
68-1	12511-12514	The	_
68-2	12515-12523	parallel	_
68-3	12524-12527	ICA	_
68-4	12528-12537	estimates	_
68-5	12538-12548	components	_
68-6	12549-12551	by	_
68-7	12552-12562	maximizing	_
68-8	12563-12572	component	_
68-9	12573-12585	independence	_
68-10	12586-12592	within	_
68-11	12593-12597	each	_
68-12	12598-12602	data	_
68-13	12603-12611	modality	_
68-14	12612-12613	,	_
68-15	12614-12617	and	_
68-16	12618-12628	maximizing	_
68-17	12629-12632	the	_
68-18	12633-12647	inter-modality	_
68-19	12648-12659	association	_
68-20	12660-12668	assessed	_
68-21	12669-12674	based	_
68-22	12675-12677	on	_
68-23	12678-12687	component	_
68-24	12688-12696	loadings	_
68-25	12697-12701	from	_
68-26	12702-12705	the	_
68-27	12706-12709	two	_
68-28	12710-12720	modalities	_
68-29	12721-12722	.	_

Text=In the current work, parallel ICA extracted 15 dFNC components and 25 SNP components, which led to a total of 375 SNP-dFNC pairs for which the associations were assessed.
69-1	12723-12725	In	_
69-2	12726-12729	the	_
69-3	12730-12737	current	_
69-4	12738-12742	work	_
69-5	12743-12744	,	_
69-6	12745-12753	parallel	_
69-7	12754-12757	ICA	_
69-8	12758-12767	extracted	_
69-9	12768-12770	15	_
69-10	12771-12775	dFNC	_
69-11	12776-12786	components	_
69-12	12787-12790	and	_
69-13	12791-12793	25	_
69-14	12794-12797	SNP	_
69-15	12798-12808	components	_
69-16	12809-12810	,	_
69-17	12811-12816	which	_
69-18	12817-12820	led	_
69-19	12821-12823	to	_
69-20	12824-12825	a	_
69-21	12826-12831	total	_
69-22	12832-12834	of	_
69-23	12835-12838	375	_
69-24	12839-12847	SNP-dFNC	_
69-25	12848-12853	pairs	_
69-26	12854-12857	for	_
69-27	12858-12863	which	_
69-28	12864-12867	the	_
69-29	12868-12880	associations	_
69-30	12881-12885	were	_
69-31	12886-12894	assessed	_
69-32	12895-12896	.	_

Text=Significant SNP-dFNC associations were then identified based on Bonferroni correction (p <0.05/375).
70-1	12897-12908	Significant	_
70-2	12909-12917	SNP-dFNC	_
70-3	12918-12930	associations	_
70-4	12931-12935	were	_
70-5	12936-12940	then	_
70-6	12941-12951	identified	_
70-7	12952-12957	based	_
70-8	12958-12960	on	_
70-9	12961-12971	Bonferroni	_
70-10	12972-12982	correction	_
70-11	12983-12984	(	_
70-12	12985-12986	p	_
70-13	12987-12988	<	_
70-14	12989-12997	0.05/375	_
70-15	12998-12999	)	_
70-16	13000-13001	.	_

Text=We performed a 1000-run permutation test to assess the validity and stability of identified dFNC-SNP association by investigating the occurrences of inter-modality correlations by chance in permuted dFNC and SNP datasets.
71-1	13002-13004	We	_
71-2	13005-13014	performed	_
71-3	13015-13016	a	_
71-4	13017-13025	1000-run	_
71-5	13026-13037	permutation	_
71-6	13038-13042	test	_
71-7	13043-13045	to	_
71-8	13046-13052	assess	_
71-9	13053-13056	the	_
71-10	13057-13065	validity	_
71-11	13066-13069	and	_
71-12	13070-13079	stability	_
71-13	13080-13082	of	_
71-14	13083-13093	identified	_
71-15	13094-13102	dFNC-SNP	_
71-16	13103-13114	association	_
71-17	13115-13117	by	_
71-18	13118-13131	investigating	_
71-19	13132-13135	the	_
71-20	13136-13147	occurrences	_
71-21	13148-13150	of	_
71-22	13151-13165	inter-modality	_
71-23	13166-13178	correlations	_
71-24	13179-13181	by	_
71-25	13182-13188	chance	_
71-26	13189-13191	in	_
71-27	13192-13200	permuted	_
71-28	13201-13205	dFNC	_
71-29	13206-13209	and	_
71-30	13210-13213	SNP	_
71-31	13214-13222	datasets	_
71-32	13223-13224	.	_

Text=The null distribution was constructed with the top correlation obtained from each test run.
72-1	13225-13228	The	_
72-2	13229-13233	null	_
72-3	13234-13246	distribution	_
72-4	13247-13250	was	_
72-5	13251-13262	constructed	_
72-6	13263-13267	with	_
72-7	13268-13271	the	_
72-8	13272-13275	top	_
72-9	13276-13287	correlation	_
72-10	13288-13296	obtained	_
72-11	13297-13301	from	_
72-12	13302-13306	each	_
72-13	13307-13311	test	_
72-14	13312-13315	run	_
72-15	13316-13317	.	_

Text=We then counted the instances with correlations greater than that observed from the original data and calculated the two-tail probability as the significance level.
73-1	13318-13320	We	_
73-2	13321-13325	then	_
73-3	13326-13333	counted	_
73-4	13334-13337	the	_
73-5	13338-13347	instances	_
73-6	13348-13352	with	_
73-7	13353-13365	correlations	_
73-8	13366-13373	greater	_
73-9	13374-13378	than	_
73-10	13379-13383	that	_
73-11	13384-13392	observed	_
73-12	13393-13397	from	_
73-13	13398-13401	the	_
73-14	13402-13410	original	_
73-15	13411-13415	data	_
73-16	13416-13419	and	_
73-17	13420-13430	calculated	_
73-18	13431-13434	the	_
73-19	13435-13443	two-tail	_
73-20	13444-13455	probability	_
73-21	13456-13458	as	_
73-22	13459-13462	the	_
73-23	13463-13475	significance	_
73-24	13476-13481	level	_
73-25	13482-13483	.	_

Text=Polygenic Risk Score Analysis Additionally, we computed the polygenic risk score (PRS) for SZ of the set of thresholded SNPs (i.e., top SNPs after thresholding the SNP component), which was a linearly weighted sum of the genotype profiles with weights derived from the odds ratios of the PGC SZ GWAS (; Ripke et al., 2014).
74-1	13484-13493	Polygenic	_
74-2	13494-13498	Risk	_
74-3	13499-13504	Score	_
74-4	13505-13513	Analysis	_
74-5	13514-13526	Additionally	_
74-6	13527-13528	,	_
74-7	13529-13531	we	_
74-8	13532-13540	computed	_
74-9	13541-13544	the	_
74-10	13545-13554	polygenic	_
74-11	13555-13559	risk	_
74-12	13560-13565	score	_
74-13	13566-13567	(	_
74-14	13568-13571	PRS	_
74-15	13572-13573	)	_
74-16	13574-13577	for	_
74-17	13578-13580	SZ	_
74-18	13581-13583	of	_
74-19	13584-13587	the	_
74-20	13588-13591	set	_
74-21	13592-13594	of	_
74-22	13595-13606	thresholded	_
74-23	13607-13611	SNPs	_
74-24	13612-13613	(	_
74-25	13614-13618	i.e.	_
74-26	13619-13620	,	_
74-27	13621-13624	top	_
74-28	13625-13629	SNPs	_
74-29	13630-13635	after	_
74-30	13636-13648	thresholding	_
74-31	13649-13652	the	_
74-32	13653-13656	SNP	_
74-33	13657-13666	component	_
74-34	13667-13668	)	_
74-35	13669-13670	,	_
74-36	13671-13676	which	_
74-37	13677-13680	was	_
74-38	13681-13682	a	_
74-39	13683-13691	linearly	_
74-40	13692-13700	weighted	_
74-41	13701-13704	sum	_
74-42	13705-13707	of	_
74-43	13708-13711	the	_
74-44	13712-13720	genotype	_
74-45	13721-13729	profiles	_
74-46	13730-13734	with	_
74-47	13735-13742	weights	_
74-48	13743-13750	derived	_
74-49	13751-13755	from	_
74-50	13756-13759	the	_
74-51	13760-13764	odds	_
74-52	13765-13771	ratios	_
74-53	13772-13774	of	_
74-54	13775-13778	the	_
74-55	13779-13782	PGC	_
74-56	13783-13785	SZ	_
74-57	13786-13790	GWAS	_
74-58	13791-13792	(	_
74-59	13793-13794	;	_
74-60	13795-13800	Ripke	_
74-61	13801-13803	et	_
74-62	13804-13807	al.	_
74-63	13808-13809	,	_
74-64	13810-13814	2014	_
74-65	13815-13816	)	_
74-66	13817-13818	.	_

Text=The loading parameters from significant pICA paired components were then assessed for associations with PRS for SZ using Pearson ’ s and Spearmann ’ s rank order correlations.
75-1	13819-13822	The	_
75-2	13823-13830	loading	_
75-3	13831-13841	parameters	_
75-4	13842-13846	from	_
75-5	13847-13858	significant	_
75-6	13859-13863	pICA	_
75-7	13864-13870	paired	_
75-8	13871-13881	components	_
75-9	13882-13886	were	_
75-10	13887-13891	then	_
75-11	13892-13900	assessed	_
75-12	13901-13904	for	_
75-13	13905-13917	associations	_
75-14	13918-13922	with	_
75-15	13923-13926	PRS	_
75-16	13927-13930	for	_
75-17	13931-13933	SZ	_
75-18	13934-13939	using	_
75-19	13940-13947	Pearson	_
75-20	13948-13949	’	_
75-21	13950-13951	s	_
75-22	13952-13955	and	_
75-23	13956-13965	Spearmann	_
75-24	13966-13967	’	_
75-25	13968-13969	s	_
75-26	13970-13974	rank	_
75-27	13975-13980	order	_
75-28	13981-13993	correlations	_
75-29	13994-13995	.	_

Text=Partial Replication Study While an independent dataset with exact imaging and genomic features was unavailable for replication purpose, we implemented our proposed model on a separate, independent dataset for partial replication.
76-1	13996-14003	Partial	_
76-2	14004-14015	Replication	_
76-3	14016-14021	Study	_
76-4	14022-14027	While	_
76-5	14028-14030	an	_
76-6	14031-14042	independent	_
76-7	14043-14050	dataset	_
76-8	14051-14055	with	_
76-9	14056-14061	exact	_
76-10	14062-14069	imaging	_
76-11	14070-14073	and	_
76-12	14074-14081	genomic	_
76-13	14082-14090	features	_
76-14	14091-14094	was	_
76-15	14095-14106	unavailable	_
76-16	14107-14110	for	_
76-17	14111-14122	replication	_
76-18	14123-14130	purpose	_
76-19	14131-14132	,	_
76-20	14133-14135	we	_
76-21	14136-14147	implemented	_
76-22	14148-14151	our	_
76-23	14152-14160	proposed	_
76-24	14161-14166	model	_
76-25	14167-14169	on	_
76-26	14170-14171	a	_
76-27	14172-14180	separate	_
76-28	14181-14182	,	_
76-29	14183-14194	independent	_
76-30	14195-14202	dataset	_
76-31	14203-14206	for	_
76-32	14207-14214	partial	_
76-33	14215-14226	replication	_
76-34	14227-14228	.	_

Text=The resting-state fMRI data were collected while the participants had their eyes open (as opposed to our main analyses where resting-state fMRI data were collected in eyes closed condition).
77-1	14229-14232	The	_
77-2	14233-14246	resting-state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
77-3	14247-14251	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
77-4	14252-14256	data	_
77-5	14257-14261	were	_
77-6	14262-14271	collected	_
77-7	14272-14277	while	_
77-8	14278-14281	the	_
77-9	14282-14294	participants	_
77-10	14295-14298	had	_
77-11	14299-14304	their	_
77-12	14305-14309	eyes	_
77-13	14310-14314	open	_
77-14	14315-14316	(	_
77-15	14317-14319	as	_
77-16	14320-14327	opposed	_
77-17	14328-14330	to	_
77-18	14331-14334	our	_
77-19	14335-14339	main	_
77-20	14340-14348	analyses	_
77-21	14349-14354	where	_
77-22	14355-14368	resting-state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
77-23	14369-14373	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
77-24	14374-14378	data	_
77-25	14379-14383	were	_
77-26	14384-14393	collected	_
77-27	14394-14396	in	_
77-28	14397-14401	eyes	_
77-29	14402-14408	closed	_
77-30	14409-14418	condition	_
77-31	14419-14420	)	_
77-32	14421-14422	.	_

Text=We used resting-state functional magnetic resonance imaging (fMRI) data and single nucleotide polymorphism (SNP) data obtained from a local COBRE (center of biomedical research excellence) study.
78-1	14423-14425	We	_
78-2	14426-14430	used	_
78-3	14431-14444	resting-state	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
78-4	14445-14455	functional	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
78-5	14456-14464	magnetic	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
78-6	14465-14474	resonance	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
78-7	14475-14482	imaging	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
78-8	14483-14484	(	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
78-9	14485-14489	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
78-10	14490-14491	)	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
78-11	14492-14496	data	_
78-12	14497-14500	and	_
78-13	14501-14507	single	_
78-14	14508-14518	nucleotide	_
78-15	14519-14531	polymorphism	_
78-16	14532-14533	(	_
78-17	14534-14537	SNP	_
78-18	14538-14539	)	_
78-19	14540-14544	data	_
78-20	14545-14553	obtained	_
78-21	14554-14558	from	_
78-22	14559-14560	a	_
78-23	14561-14566	local	_
78-24	14567-14572	COBRE	_
78-25	14573-14574	(	_
78-26	14575-14581	center	_
78-27	14582-14584	of	_
78-28	14585-14595	biomedical	_
78-29	14596-14604	research	_
78-30	14605-14615	excellence	_
78-31	14616-14617	)	_
78-32	14618-14623	study	_
78-33	14624-14625	.	_

Text=After preprocessing, we obtained data from a total of 135 participants (72 healthy controls and 63 SZ patients matched for age) for which both fMRI and SNP data were collected.
79-1	14626-14631	After	_
79-2	14632-14645	preprocessing	_
79-3	14646-14647	,	_
79-4	14648-14650	we	_
79-5	14651-14659	obtained	_
79-6	14660-14664	data	_
79-7	14665-14669	from	_
79-8	14670-14671	a	_
79-9	14672-14677	total	_
79-10	14678-14680	of	_
79-11	14681-14684	135	_
79-12	14685-14697	participants	_
79-13	14698-14699	(	_
79-14	14700-14702	72	_
79-15	14703-14710	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
79-16	14711-14719	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
79-17	14720-14723	and	_
79-18	14724-14726	63	_
79-19	14727-14729	SZ	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
79-20	14730-14738	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
79-21	14739-14746	matched	_
79-22	14747-14750	for	_
79-23	14751-14754	age	_
79-24	14755-14756	)	_
79-25	14757-14760	for	_
79-26	14761-14766	which	_
79-27	14767-14771	both	_
79-28	14772-14776	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
79-29	14777-14780	and	_
79-30	14781-14784	SNP	_
79-31	14785-14789	data	_
79-32	14790-14794	were	_
79-33	14795-14804	collected	_
79-34	14805-14806	.	_

Text=Using the same steps mentioned for our main analyses, we preprocessed both fMRI and SNP data.
80-1	14807-14812	Using	_
80-2	14813-14816	the	_
80-3	14817-14821	same	_
80-4	14822-14827	steps	_
80-5	14828-14837	mentioned	_
80-6	14838-14841	for	_
80-7	14842-14845	our	_
80-8	14846-14850	main	_
80-9	14851-14859	analyses	_
80-10	14860-14861	,	_
80-11	14862-14864	we	_
80-12	14865-14877	preprocessed	_
80-13	14878-14882	both	_
80-14	14883-14887	fMRI	_
80-15	14888-14891	and	_
80-16	14892-14895	SNP	_
80-17	14896-14900	data	_
80-18	14901-14902	.	_

Text=As the genomic features, we identified the same 1546 pre-selected SNPs as our main analyses.
81-1	14903-14905	As	_
81-2	14906-14909	the	_
81-3	14910-14917	genomic	_
81-4	14918-14926	features	_
81-5	14927-14928	,	_
81-6	14929-14931	we	_
81-7	14932-14942	identified	_
81-8	14943-14946	the	_
81-9	14947-14951	same	_
81-10	14952-14956	1546	_
81-11	14957-14969	pre-selected	_
81-12	14970-14974	SNPs	_
81-13	14975-14977	as	_
81-14	14978-14981	our	_
81-15	14982-14986	main	_
81-16	14987-14995	analyses	_
81-17	14996-14997	.	_

Text=In order to identify the similar imaging features (i.e., dFNC states), we implemented the following two-step replication: (i) using a spatially constrained ICA approach, we computed subject specific maps and timecourses for the 49 ICNs and computed the sliding-window based dynamic connectivity matrices for each subject, and (ii) using k-means clustering approach while using the original dFNC states (i.e., from our main study) as stating points for clusters, we identified 5 cluster centroids/dFNC states for each subject.
82-1	14998-15000	In	_
82-2	15001-15006	order	_
82-3	15007-15009	to	_
82-4	15010-15018	identify	_
82-5	15019-15022	the	_
82-6	15023-15030	similar	_
82-7	15031-15038	imaging	_
82-8	15039-15047	features	_
82-9	15048-15049	(	_
82-10	15050-15054	i.e.	_
82-11	15055-15056	,	_
82-12	15057-15061	dFNC	_
82-13	15062-15068	states	_
82-14	15069-15070	)	_
82-15	15071-15072	,	_
82-16	15073-15075	we	_
82-17	15076-15087	implemented	_
82-18	15088-15091	the	_
82-19	15092-15101	following	_
82-20	15102-15110	two-step	_
82-21	15111-15122	replication	_
82-22	15123-15124	:	_
82-23	15125-15126	(	_
82-24	15127-15128	i	_
82-25	15129-15130	)	_
82-26	15131-15136	using	_
82-27	15137-15138	a	_
82-28	15139-15148	spatially	_
82-29	15149-15160	constrained	_
82-30	15161-15164	ICA	_
82-31	15165-15173	approach	_
82-32	15174-15175	,	_
82-33	15176-15178	we	_
82-34	15179-15187	computed	_
82-35	15188-15195	subject	_
82-36	15196-15204	specific	_
82-37	15205-15209	maps	_
82-38	15210-15213	and	_
82-39	15214-15225	timecourses	_
82-40	15226-15229	for	_
82-41	15230-15233	the	_
82-42	15234-15236	49	_
82-43	15237-15241	ICNs	_
82-44	15242-15245	and	_
82-45	15246-15254	computed	_
82-46	15255-15258	the	_
82-47	15259-15273	sliding-window	_
82-48	15274-15279	based	_
82-49	15280-15287	dynamic	_
82-50	15288-15300	connectivity	_
82-51	15301-15309	matrices	_
82-52	15310-15313	for	_
82-53	15314-15318	each	_
82-54	15319-15326	subject	_
82-55	15327-15328	,	_
82-56	15329-15332	and	_
82-57	15333-15334	(	_
82-58	15335-15337	ii	_
82-59	15338-15339	)	_
82-60	15340-15345	using	_
82-61	15346-15353	k-means	_
82-62	15354-15364	clustering	_
82-63	15365-15373	approach	_
82-64	15374-15379	while	_
82-65	15380-15385	using	_
82-66	15386-15389	the	_
82-67	15390-15398	original	_
82-68	15399-15403	dFNC	_
82-69	15404-15410	states	_
82-70	15411-15412	(	_
82-71	15413-15417	i.e.	_
82-72	15418-15419	,	_
82-73	15420-15424	from	_
82-74	15425-15428	our	_
82-75	15429-15433	main	_
82-76	15434-15439	study	_
82-77	15440-15441	)	_
82-78	15442-15444	as	_
82-79	15445-15452	stating	_
82-80	15453-15459	points	_
82-81	15460-15463	for	_
82-82	15464-15472	clusters	_
82-83	15473-15474	,	_
82-84	15475-15477	we	_
82-85	15478-15488	identified	_
82-86	15489-15490	5	_
82-87	15491-15498	cluster	_
82-88	15499-15513	centroids/dFNC	_
82-89	15514-15520	states	_
82-90	15521-15524	for	_
82-91	15525-15529	each	_
82-92	15530-15537	subject	_
82-93	15538-15539	.	_

Text=These dFNC states were then used as the imaging features for our proposed pICA framework.
83-1	15540-15545	These	_
83-2	15546-15550	dFNC	_
83-3	15551-15557	states	_
83-4	15558-15562	were	_
83-5	15563-15567	then	_
83-6	15568-15572	used	_
83-7	15573-15575	as	_
83-8	15576-15579	the	_
83-9	15580-15587	imaging	_
83-10	15588-15596	features	_
83-11	15597-15600	for	_
83-12	15601-15604	our	_
83-13	15605-15613	proposed	_
83-14	15614-15618	pICA	_
83-15	15619-15628	framework	_
83-16	15629-15630	.	_

Text=The proposed algorithm proceeds in two stages, consisting of independent component computation at group and subject levels, respectively.
84-1	15631-15634	The	_
84-2	15635-15643	proposed	_
84-3	15644-15653	algorithm	_
84-4	15654-15662	proceeds	_
84-5	15663-15665	in	_
84-6	15666-15669	two	_
84-7	15670-15676	stages	_
84-8	15677-15678	,	_
84-9	15679-15689	consisting	_
84-10	15690-15692	of	_
84-11	15693-15704	independent	_
84-12	15705-15714	component	_
84-13	15715-15726	computation	_
84-14	15727-15729	at	_
84-15	15730-15735	group	_
84-16	15736-15739	and	_
84-17	15740-15747	subject	_
84-18	15748-15754	levels	_
84-19	15755-15756	,	_
84-20	15757-15769	respectively	_
84-21	15770-15771	.	_

Text=First, a group-level ICA is performed to extract information in the form of group ICs from preprocessed fMRI data of multiple subjects.
85-1	15772-15777	First	_
85-2	15778-15779	,	_
85-3	15780-15781	a	_
85-4	15782-15793	group-level	_
85-5	15794-15797	ICA	_
85-6	15798-15800	is	_
85-7	15801-15810	performed	_
85-8	15811-15813	to	_
85-9	15814-15821	extract	_
85-10	15822-15833	information	_
85-11	15834-15836	in	_
85-12	15837-15840	the	_
85-13	15841-15845	form	_
85-14	15846-15848	of	_
85-15	15849-15854	group	_
85-16	15855-15858	ICs	_
85-17	15859-15863	from	_
85-18	15864-15876	preprocessed	_
85-19	15877-15881	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
85-20	15882-15886	data	_
85-21	15887-15889	of	_
85-22	15890-15898	multiple	_
85-23	15899-15907	subjects	_
85-24	15908-15909	.	_

Text=Then the group information is used as guidance for the subject-level ICA, computed separately on the fMRI data of each subject.
86-1	15910-15914	Then	_
86-2	15915-15918	the	_
86-3	15919-15924	group	_
86-4	15925-15936	information	_
86-5	15937-15939	is	_
86-6	15940-15944	used	_
86-7	15945-15947	as	_
86-8	15948-15956	guidance	_
86-9	15957-15960	for	_
86-10	15961-15964	the	_
86-11	15965-15978	subject-level	_
86-12	15979-15982	ICA	_
86-13	15983-15984	,	_
86-14	15985-15993	computed	_
86-15	15994-16004	separately	_
86-16	16005-16007	on	_
86-17	16008-16011	the	_
86-18	16012-16016	fMRI	_
86-19	16017-16021	data	_
86-20	16022-16024	of	_
86-21	16025-16029	each	_
86-22	16030-16037	subject	_
86-23	16038-16039	.	_

Text=A list of key acronyms and definitions can be found in Tables S1 and S2.
87-1	16040-16041	A	_
87-2	16042-16046	list	_
87-3	16047-16049	of	_
87-4	16050-16053	key	_
87-5	16054-16062	acronyms	_
87-6	16063-16066	and	_
87-7	16067-16078	definitions	_
87-8	16079-16082	can	_
87-9	16083-16085	be	_
87-10	16086-16091	found	_
87-11	16092-16094	in	_
87-12	16095-16101	Tables	_
87-13	16102-16104	S1	_
87-14	16105-16108	and	_
87-15	16109-16111	S2	_
87-16	16112-16113	.	_

